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CHAPTER I 
 
INTRODUCTION 
 
Motivation & Significance 
The adaptive immune response is a highly complex, critical life system which allows the 
human body to combat never before seen pathogens.  This intricate dance which is called 
immunity involves well-timed sequences of signaling mechanisms and cellular interactions 
which is constantly working to maintain that delicate balance between outright war upon 
invaders and preservation of that which is self.  A misjudged step in either direction results in 
either defeat or self-destruction.  Lack of an intact immune system as observed in individuals 
diagnosed with severe combined immunodeficiency (SCID) or acquired immune deficiency 
syndrome (AIDS) demonstrates its incompatibility with life as both syndromes are fatal without 
drastic medical intervention.  In addition to the primary duties of warding off potentially life 
threatening invaders, the immune system also plays major roles in wound healing[1-4], 
autoimmune diseases, tumor growth and survival[2;5], as well as producing chemical signaling 
agents that communicate and influence various bodily tissues[6] including both the heart[7] and 
the brain[8;9].  Thus, understanding the goings on of the immune system is an area of intense 
scrutiny and certain to have widespread impact in human biology and medicine.   
T cells play a central role in cellular mediated adaptive immune responses as they are 
responsible for recognizing and responding to foreign/dangerous antigens.  Deciphering the 
modus operandi of T cells in action is of utmost importance understanding the adaptive immune 
response as a whole. While the intracellular signaling pathways the govern T cell response are 
some of the most intensely studied, the intricacies of many signaling mechanisms remain 
unclear.  Conventional cell culture methodologies involve analyzing bulk responses from million 
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of T cells which may average out key, rare signaling events important in the progression of a 
successful immune response.  Thus it is desirable to follow both individual and populations of 
cells over time to obtain a clearer understanding of T cell signaling states.  However, studying 
single T cells over time is difficult as their non-adherent nature generates the need for a method 
of tethering cells to a cell culture surface using antibodies or fibronectin which induce intracellular 
signaling cascades on their own.   Hence, the main motivating factor driving this project was the 
desire to create a platform which overcomes limitations in conventional immunological and cell 
culture techniques to allow key information concerning T cell signaling pathways associated with 
cellular activation to be ascertained in an efficient as well as economic manner.  The primary 
objective being the development, validation, and successful implementation of a novel 
microfluidic platform that allows controlled activation, manipulation, and monitoring of signaling 
pathways in multiple single T cells simultaneously.   
  
Overview 
 The primary objective of this research was to develop a microfluidic platform for the 
study of T cell signaling pathways.   To accomplish this, the following goals were set forth: (1) 
Design and produce a microfluidic device capable of passively trapping hundreds of single T 
cells in parallel. (2) Validate the ability of this device to trap primary T cells without 
compromising viability as well as maintain primary T cells for at least 24 hours within the device 
with a similar mortality rate as that found in cell culture.   Long-term observation of T cells is 
essential to fully understanding the outcome of signaling cascades stimulated upon activation 
and as such this platform must be able to stably sustain primary T cells for extended lengths of 
time.  (3) Demonstrate the ability to activate primary T cells within the microfluidic device using 
chemical, antibody and cellular based stimulation methods.  While cellular based activation 
methods are most relevant physiologically, all three methods are utilized in conventional 
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Figure 1.  Illustration of Immune synapse 
immunological procedures and thus must be included to add credence to the assertion that this 
platform be a suitable substitute to current methodologies.  (4)  Utilize the microfluidic platform 
to study intracellular calcium signaling in primary T cells during activation.  Calcium release from 
intracellular stores is a very early event in T cell activation and one that had been extensively 
characterized.  However, utilizing this platform which allows the analysis of hundreds of 
individual cells over time may reveal nuances not clearly apparent in previous studies.  At the 
very least, these experiments will further validate our platform as a useful tool in the study of T 
cell signaling. 
 
Background 
 
Immunology & T cell Biology 
Thymocytes (T cells) are the 
major signal transducer with respect 
to the adaptive immune response in 
mammalian systems.  These cells 
accept generic information from 
antigen presenting cells (APCs), 
rapidly distinguish between dangerous 
and benign peptides, then initiate 
signaling pathways to spark immune 
reaction specific to antigens perceived 
as threatening.  Capabilities such as 
these make T cells an ideal target for developing cell based biosensor technologies.  However, 
in order to utilize T cells to discriminate between or identify various stimuli, the internal signaling 
cascades must be well understood.  Many of the experiments described within this proposal are 
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designed to facilitate the ability to gain more insight into the intricacies of T cell signaling 
pathways by developing a platform for studying multiple independent signaling pathways in 
single cells.  Preliminary, proof-of-principle experiments will be based upon well known signaling 
events occurring during T cells activation. 
 
Antigen Processing & Immune Synapse 
 Antigen presenting cells, primarily dendritic cells, can be considered the sentinels of the 
adaptive immune system as their primary functions is to indiscriminately break down all 
peptides, including those of self and non-self origins, and express the peptide fragments bound 
to the MHC receptor.  It is the MHC complex to which the T cell receptor (TCR) binds to and 
discriminates between dangerous and non-threatening antigens.  There are two classes of MHC 
receptor, class I MHC and class II MHC that respond to cytosolic peptides or endosomal 
peptides, respectively.  While not an absolute division, the MHC class I receptors present mainly 
viral peptides while the MHC class II bind primarily bacterial antigens.  Cytotoxic T cells (CD8+) 
interact with class I MHC while helper T cells (CD4+) bind the class II MHC receptor.   
The immune synapse is formed by the strong interaction between T cells and antigen 
presenting cells (APCs) during which information on a particular antigen is transmitted to the T 
cell.  If the MHC receptor contains a self, non-dangerous peptide fragment, the binding affinity 
between the TCR and the MHC receptor will be too week to transmit a signal resulting in the 
dissociation of the T cell and APC.  When a pathogen is presented instead, the TCR and MHC 
bind tightly and recruit additional signaling and adhesion molecules to the synapse as shown in 
figure 1.  This results in the amplification and propagation of activation signals through 
intracellular pathways causing stimulatory cytokine production and clonal expansion of the 
reacting T cell line (details described below). 
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Figure 2.  Major intracellular T cell activation pathways leading to 
the production of IL-2 and IL-2Rα. 
T Cell Activation Pathways 
Given the centrality of T cells and their activation to this proposal, it is useful to 
understand the sequence of events that occur with T cell activation.  Figure 2 illustrates the 
major signaling pathways leading to IL-2 and IL-2Rα production. Successful engagement of the 
T-cell receptor (TCR) and coreceptors by antigen presenting cells (APCs) results in a cascade 
of intracellular events that ultimately result in the transcription of gene products necessary for T-
cell proliferation and effector functions.  This cascade of events can initiate several important 
signaling pathways, including the DAG (diacylglycerol), IP3 (inositol 1,4,5-triphosphate), and 
MAPK (mitogen-activated protein kinase) pathways.  Activation of phospholipase C (PLCγ1) by 
adaptor proteins and ZAP-70 results in the cleavage of phosphatidylinositol 4,5bisphosphate 
(PIP2) to produce IP3 and DAG.  IP3 binds to the endoplasmic reticulum and releases calcium 
stores. This increase in intracellular calcium  concentration activates transcription factor NFAT 
(nuclear factor of activation in T cells), which then moves to the nucleus.  DAG recruits and 
activates protein kinase C 
(PKC) in the lipid membrane 
[10].  There are several 
calcium-dependant and -
independent isoforms of PKC 
whose substrates are not 
clearly defined.  However, 
studies have shown that PKC 
is integral in the activation of 
NFκB (nuclear factor kappa 
beta)[11] and AP-1[12].  In 
particular, the PKC θ isoform is essential for the production of TCR-induced IL-2[13].  Once in 
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the nucleus, the transcription factors NFAT, NFκB, and AP-1 act in concert to coordinate the 
activation of many genes involved in host defense and inflammatory responses, such as 
cytokine IL-2 to promote T cell activation and proliferation.  It is estimated that together these 
transcription factors generate more than 250 gene products upon activation.  
In vivo, T cell activation occurs by direct cell-cell contact with an APC.  In vitro, T cell 
stimulation can be artificially induced by using 2 chemicals, phorbol myrastoyl acetate ( phorbol 
ester or PMA) and ionomycin[14].  Both PKC and Ras-GRP (precursor to MAPK cascade) 
possess phorbol ester binding sites and are thus stimulated by PMA resulting in the activation of 
NFkb and AP-1[15].  Ionomycin stimulates calcium release from intracellular stores which 
results in the activation of NFAT.  Thus, administration of these two chemicals simultaneously 
upregulates all three transcription factors.  
NFκB: Five members of the mammalian NFκB/Rel family have been identified. The 
preponderant form of NFκβ in most cells consists of a heterodimer containing p50 and RelA 
(p65), which contains a transactivation domain[16-18].  In quiescent cells, NFκB complexes are 
sequestered in the cytoplasm by inhibitory proteins (IκB-α, IκB -β, IκB -ε)[19].  Stimulation of the 
NFκB pathway is mediated by diverse signal transduction cascades, resulting in 
phosphorylation of IκBs.  Phosphorylated IκB-α (or IκB -β) is ubiquitinated and degraded by the 
26S proteasome, allowing nuclear translocation of the NFκB complexes [20;21].  Activation of 
NFκB is necessary for maximal transcription of many adhesion molecules, enzymes, cytokines, 
and chemokines important in the initiation of inflammation and has been shown to be an 
essential component in signaling pathways of macrophages, dendritic cells, T and B-
lymphocytes[22;23].  Still, the independent effects of cell and tissue specific activation of this 
transcription factor complex are largely undefined. 
NFAT:  There are four members of the NFAT family (NFAT 1-4), all of which share a 
high degree of DNA binding region sequence homology with the NFkB/Rel family of 
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transcription factors.  NFAT 1 and 4 are constitutively expressed in T cells, while NFAT-2 
transcription is induced by T cell activation.  Previous studies have shown that NFAT 1,2 ,and 4 
exert overlapping control in the initiation of IL-2 production in that cells may be deficient in one 
isoform without suffering significant decrease in IL-2 levels.  However, cells deficienct in 2 or 
more isoforms result in marked impairment of IL-2 production [24].  Under resting conditions, a 
phosphorylated NFAT resides in the cytosol.  Increase in intracellular calcium during activation 
results in calcineurin activation and subsequent binding to NFAT.  The NFAT/calcineurin 
complex rapidly (5-10 minutes following activation translocates to the nucleus where NFAT 
associates with AP-1 to initiate transcription of various gene products including IL-2, IL-4, Il-5, 
TNF-α, and GM-CSF [24-27] ).  High intracellular calcium levels are required to sustain NFAT 
activity in the nucleus as calcineurin dissociation results in the movement of NFAT from the 
nucleus back to the cytosol [24]. 
AP-1:  Activator protein -1 (AP-1) is a potent transcription factor consisting of 2 basic 
region-leucine zipper proteins (bZIP), c-Jun and c-Fos [28].  Ligation of the TCR activates 
MAPK cascades, ERK (extracellular receptor-activated kinase) and JNK (c-Jun N-terminal 
Kinase), that lead to the de novo synthesis of c-Jun and c-Fos in parallel pathways, 
respectively.  A third MAPK, FRK, facilitates the dimerization of c-Jun and c-Fos by 
phosphorylating the C-terminal of c-Fos.  Both c-Jun and c-Fos can act as transcription factors, 
but are more stable as a heterodimer and thus increase their DNA-binding ability[29].  In T cells 
AP-1 is known to associate with NFAT and NFκB in the production of IL-2, among other gene 
products.   
IL-2:  Interleukin-2 (IL-2), also known as T cell growth factor, is the major activating 
cytokine in T cells.  Antigen stimulated naïve T cells (both CD4+ and CD8+) generate high 
levels of IL-2 which acts in autocrine fashion to promote clonal expansion, expression of IL-2 
receptor-alpha (IL-2Rα), and increased cytokine production[10].  Because IL-2 is not produced 
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in naïve T cells, it is a good indicator of T cell activation.  IL-2 synthesis requires transcriptional 
activation by NFκB, NFAT, and AP-1 and typically peaks 8 to 12 hours following antigen 
stimulation in primary T cells [30]. 
Jurkat T cells/ T cell hybridoma:  Generating a stable cell line from T cells freshly 
isolated from peripheral blood samples is difficult due to their inherent volatility and relatively 
short lifetime.  In addition, the peripheral blood will contain a very diverse population of T cells in 
terms of maturity and receptor type.  T cell hybridomas overcome these limitations by fusing a 
particular normal T cell line with a lymphoma cell line.  Fused cells are immortal and thus are 
stable over time, but also retain many of the characteristics of the normal T cell.  In this 
experiment we propose to use Jurkat cells (ATCC, clone E6-1), a well studied T cell hybridoma 
generated from  leukemia lymphoma by Schneider et al [31].   However, the Jurkat cell line is 
only a model of normal CD4 T cells.  Because of their ease of use Jurkat cells will be used to 
optimize many of the experimental protocols, but the ultimate goal is to conduct experiments 
with primary CD4+ T cells isolated from peripheral blood of human donors in order to generate 
more scientifically relevant results.  
 
Conventional Cell Cuture Techniques 
 Because the primary objective of this research is to develop a platform to replace current 
immunological experimental techniques, it is useful to summarize the strengths and 
weaknesses of some of the most widely used tools.   The reason for developing the microfluidic 
platform is to have an easy method of analyzing multiple single T cells over extended periods of 
time.  The following techniques are undoubtedly important in immunological experimentation, 
but none alone are able to fulfill these criteria. 
Flourescence Activated Cell Sorting (FACS):  FACS is a highly useful flow cytometry 
technique for quickly identifying subset populations in bulk aliquots of cells and is one of the 
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most frequently used techniques in the field of immunology.  The reason being that the state 
(activated vs anergic, mature vs. immature) of an immune cell can often be narrowed by the 
protein expressed on the cell surface.  These cell surface protein are easily tagged with 
fluorescently labeled antibodies and FACS provides a methods for quickly assessing the size of 
labeled and unlabeled cells within a large population. 
FACS works by employing a laser beam (most commercial FACS machines have 
multiple lasers which are utilized based upon the fluorescent markers labeling the cells) focused 
upon a fluid stream that is hydrodynamically focused such that the width is on the order of a 
single cell, thus allowing single cell analysis.  Several detectors are arranged such that forward 
scatter, side scatter, and fluorescence signals are simultaneously collected from the passing 
cells.   This collection of scatter data combined with one or more fluorescent marker signals, is 
used in a statistical manner to draw conclusions on the state of the cells as well as to sort them 
into predefined populations for further study.  FACS is extremely fast requiring only minutes to 
analyze millions of individual cells and is one of the few experimental techniques that allows for 
the analysis single cells.   However, the data collected from FACS is a single snapshot of the 
cell in time.  Obtaining time resolved information required multiple FACS runs most often on 
different cells from the same culture.  It is nearly impossible to track any given individual cell 
over time. 
Cell Culture Based Methods:  The term cell culture based methods is meant to refer to 
experiments completed in the context of cell culture dish.  Most experiments designed to gather 
information on entire populations of cells typically begin in cell culture as the environmental 
conditions of the cells in question are modified to address a given hypothesis, but in the end the 
analysis is very often performed using FACS.  However, cell culture has the potential to allow 
the assessment of a given cell or population of cells over time.  There are several issues with 
traditional cell culture experimentation that are particularly significant in studying immune cells. 
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One such issue is the typically large volume of media compared to cell volume in 
traditional cell culture setup.  For example, it is customary to culture primary CD4+ T cells at a 
ratio of 5x105 cells/ml such that there is approximately 10 µl of cell culture media available per 
cell. Primary naïve CD4+ T cells have a diameter of approximately 7 µm which gives a cellular 
volume of close to one picoliter.  Thus, the media to cell volume ratio is 10µl:1pl which is 
equivalent to a ratio of 1x106 to 1.  While this setup provides a surplus of nutrients for cells, this 
superfluous volume also hinders normal T cell function.  It is well known that both autocrine and 
paracrine signaling agents such as cytokines or chemokines are absolutely critical in the 
functioning of a normal T cell.  The tremendous media to cell volume ratio results in the dilution 
of the cell based signals.  In addition, cell-cell interactions are also very important in the 
progression of immune response, especially during activation.  Dendritic cells (DCs) are larger 
than T cells with an approximate cellular volume closer to 5 picoliters such that the media to cell 
volume ratio is reduced to roughly 5x106:1, but this is still sufficiently large that there is 
significant media volume between cells.  Activation experiments requiring DCs and T cells to 
closely interact with one another must allow sufficient time for cells to “find” each other.  This 
process can be hampered by the dilution of intercellular chemical agents.  In addition, it is 
difficult to analyze the initial interactions between DCs and T cells as the exact position and time 
of interface is nearly impossible to predict.  The solution to this problem leads us to the second 
major drawback of traditional cell culture techniques used to study T cell activation: tethering 
cells to the cell culture surface. 
Because immune cells are non-adherent and there typically exists a large media to cell 
volume ratio in culture, studying the interactions between cells can be extremely difficult.  One 
solution to this problem is attempting to tether one cell population to the cell culture surface so 
that there is a fixed point at which you expect the cellular interactions to occur.  This is usually 
done using antibodies to cell surface proteins or an adhesive protein such as fibronection.  The 
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problem with this approach is that any type of cell surface binding event will result in the 
triggering of internal signaling cascades that will affect the state of the cell.  There are more 
passive methods of isolating cells such as optical trapping, but this allows the study of only a 
few cells at a time and requires an expensive setup.  Thus, it is extremely desirable to have a 
method for passively isolating cells to minimize the variables during a given experiment without 
the need for a highly specialized and expensive experimental assembly. 
 
Microfluidics 
 
Overview 
Microfluidics falls under the umbrella of “Lab-on-a-chip” technology, which in essence 
means translating traditional lab bench scale experiments to a micro-, or even nano-, scale.  
There are several reason that this is desirable, the first being the ability to integrate several 
laboratory functions in a single chip, thus decreasing time of experimentation and maximizing 
output.  In addition, then miniaturization itself has several key advantages including reduction in 
reagents required for a given experiment (including cells for cell-based applications), increase in 
reaction times due to small volumes yielding shorter diffusion times[32;33], as well as tighter 
control of the system as a whole due to small size and low fluid volume[34-36].  Finally, once a 
platform has been designed it is typically very easy and inexpensive to mass produce 
disposable chips[37].   
The materials used in making these devices depends upon the intended application, but 
for many biological including those presented within this body of work, microfluidic devices are 
constructed of polydimethylsiloxane (PDMS).  PDMS is an elastomeric compound that is 
optically transparent making it well suited for microscopy applications and bio-inert such that 
biological organism or fluids do not react with the device surface upon contact[38].  However, 
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both PDMS and glass surfaces are easily functionalized using methods such as self-assembled 
monolayers (SAMs) associated with cell surface antibodies[37], or coating with bioreactive 
compounds (e.g. fibronectin)[39].  Furthermore, PDMS is gas permeable to nonpolar gases 
such as oxygen and carbon dioxide, a characteristic which is extremely important when dealing 
with mammalian cell culture that requires a steady exchange of oxygen and carbon dioxide to 
maintain metabolic equilibrium[37].   
 
Fabrication 
Microfluidic devices are fabricated using soft lithography, a process that has roots in the 
photolithographic methods developed to manufacture microelectronics.  The process was 
adapted for microfluidic 
applications by lab-on-
a-chip pioneers, 
George Whitesides and 
Steve Quake[33;37;40].  
A simplified overview of 
the current fabrication 
process is illustrated in 
Figure 3.   The design 
of the microfluidic device is first composed using Auto-CAD (Autodesk, Inc.), then transferred to 
a chrome mask via a commercial partner.  A master is generated from the mask by first spin 
coating a layer of a photo-curable polymer, also known as photoresist, onto a silicon wafer.  The 
photoresist is then exposed through the chrome mask with UV light.  Areas that have been 
etched on the chrome will allow UV rays to penetrate the mask and cured the exposed 
photoresist.  The uncured photoresist is then washed away leaving positive relief structures on 
Remaining Photo Resist
Wafer
Wafer
UV light
Mask
Wafer
Photo Resist
Wafer
PDMS
Spin coat 
photo resist 
onto silicon 
wafer
Expose photo 
resist through 
mask 
Pour PDMS 
& cure 
Remove PDMS 
from wafer & 
bond to glass
PDMS
Glass
Wafer
microfluidic
channels
positive relief 
structures
Figure 3.  Overview of microfluidic device fabrication. 
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the surface of the silicon wafer.  This becomes the master; a mold which can be used 
repeatedly to generated microfluidic devices out of PDMS.  To generate a device from the 
master, a thick layer of PDMS is poured over the master and allowed to cure for 1 hour at 70oC.  
The PDMS is then carefully peeled from the master.  Narrow access ports are punched using 
standard 25 gauge hypodermic needle just prior to plasma bonding the device to a glass 
coverslip.  The positive relief structure from the master result in open channels that are bound 
on the top and sides by PDMS, and glass on the bottom.  The device is now ready for cellular 
applications. 
  
Microfluidic devices to study single cells 
The utilization of microfluidic devices for cellular applications has exploded over the past 
10 years with the promise of lower production and reagent cost, tighter control of experimental 
paramenters, and quicker reaction times along with reduced diffusion times compared to 
traditional cell culture techniques[34;36;41].  The latter point opens the possibility of 
interrogating cellular activities that occur in time scales to quick to observe with conventional 
techniques[42].  Flexible and relatively easy fabrication allows incorporation of more 
complicated microfluidic designs including valves, pumps, and switches which enhance the 
manipulative ability of the cellular micro-environment[33;37;40].  Furthermore, culturing cells in a 
constant flow-thru environment is arguably more physiologically relevant than maintaining cells 
in a relatively large, stagnant pool of media as done in conventional cell culture.   
The ability to maintain mammalian cells for extended periods of time has been 
demonstrated in adherent cell lines[43-45].  Cells readily adhere to the glass surface 
(sometimes functionalized to promote adhesion) and are able to be studied individually or en 
mass.  When working with suspension cells, however, the same sequestration problem that 
plagues traditional cell culture methods is true for microfluidics as well.  Methods to adhere cells 
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to a surface (antibodies or adhesion proteins) will induce undesired intracellular signaling 
pathways that alter the state of the cell.   
One solution to this problem is to use suction to hold a cell in a “trap”, which has been 
demonstrated to be very effective with cardiac myocytes[46-48].  However, T cells, one of the 
main focuses of this research, are extremely small compared to cardiac myocytes with 
diameters of naïve T cells ranging between 5-7 µm.  The diameter of the suction channels 
would ideally be much smaller than the diameter of the cell, but this aspect ratio is nearing the 
resolution limit for out current fabrication facilities.  Furthermore, T cells are highly deformable 
and sensitive to pressure.  Suction easily lyses these cells and those that remain intact are 
destined for apoptosis.  Thus, for analysis of T cells, it is essential to have a passive trapping 
process.   
McClain et al avoided the 
trapping problem in their novel 
platform to study Jurkat T 
cells[49].  Their high-throughput 
device allowed the interrogation 
and subsequent lysis of 
individual cells as they passed 
through the device.  We are 
interested, however, in long term 
analysis of T cells and thus this 
technique isn’t applicable.  
A truly passive trapping mechanism was developed by Wheeler et al[35].  A clever 
device design incorporating on-chip valves allowed high precision control of fluid flow such that 
individual T cells could be directed into a bucket-shaped chamber (see Figure 4).  Once trapped, 
 
Figure 4.  Single-cell analysis device. (A) Schematic of device: 
fluidic channels are dark; control channels are light. R1-R5 are 
reactant inlets, SB and FB are shield and focusing buffer inlets, 
respectively. Valves are actuated by applying pressure to 
control inlets V1-V8. Pumps are activated by actuating P1-P3 
or P4-P6 in series. The serpentine regions of reagent and 
shield buffer channels diminish flow pulsing resulting from 
pump activation. Inset: closeup of cell trapping region. Cells are 
pushed by hydrostatic pressure from cell inlet to waste; they 
are focused to the center of the stream by the focusing buffer. 
Note the point of stagnation formed at *. (B) CCDimage of an 
individual Jurkat T-cell trapped in cell dock. 
Reproduced from Wheeler et al. Anal Chem. 2003, 75, 3249-3254 
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the intricate hydrodynamic controls allowed the cell to be directly addressable by dyes, 
stimulants, or lysing agents.  However, the design was arranged such that only a single cell was 
trapped and interrogated during a single experiment.   This is highly inefficient for collecting 
information concerning a population of T cells.  To maximize the quantity and quality of data 
extracted from a given experiment, it is desirable to have many (hundreds to thousands) 
individually trapped and fluidically addressable T cells within a single microfluidic platform.  To 
our knowledge, such a platform for analysis of T cells does not yet exist.  Thus the impetus to 
develop and validate a microfluidic platform designed specifically to analyze T cells.  Such a 
platform will facilitate the long-term study of hundreds of passively trapped individual T cells 
simultaneously, as well as other suspension cells of the immune system, without using 
antibodies or proteins to adhere cells to the culture surface and still allowing microscopic 
evaluation.  In addition, this cell-based platform will be easily compatible with a multitude of 
detection modalities to maximize information extracted from any given experiment.   
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CHAPTER II 
 
 
 
QUANTUM DOT PROBES FOR MONITORING DYNAMIC CELLULAR RESPONSE: 
REPORTERS OF T CELL ACTIVATION 
 
 
 
Abstract 
Antibody-conjugated quantum dots (QDs) have been used to map the expression 
dynamics of the cytokine receptor interleukin-2 receptor (IL-2R) following Jurkat T cell 
activation.  Maximal receptor expression was observed 48 h after activation, followed by a sharp 
decrease consistent with IL-2R internalization subsequent to IL-2 engagement.  Verification of T 
cell activation and specificity of QD labeling were demonstrated using fluorescence microscopy, 
ELISA, and FACS analyses.  These antibody conjugates provide a versatile means to rapidly 
determine cell state and interrogate membrane associated proteins involved in cell signaling 
pathways.  Ultimately, incorporation with a microfluidic platform capable of simultaneously 
monitoring several cell signaling pathways will aid in toxin detection and discrimination. 
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Introduction 
Quantum Dots (QDs) have shown a great deal of promise in fluorescent imaging 
applications since their first reported use as biological probes in 1998 [1], [2]. Their unique 
photophysical properties overcome several limitations of conventional fluorophores. Specifically, 
QDs continuous absorption spectra and narrow, size-dependant fluorescent emission make 
them ideally suited for multiplexed fluorescence detection, while their improved brightness and 
photostability permit long-term, dynamic imaging applications. Biological specificity has been 
introduced through a number of different surface modifications. Some noteworthy imaging 
applications have utilized small molecule [3], peptide [4], [5], and antibody [6]–[8] QD 
 
Figure 5.  Signaling pathway associated with T cell activation. Engagement of the TCR and coreceptors by an APC 
results in a signaling cascade producing transcription factors NFAT, NFkB, and AP-1 required for successful activation 
of the T cell and expression of IL-2 and IL-2R. As indicated, chemical stimulation can occur by treatment with PMA 
and ionomycin. PMA activates PKC, initiating the signaling cascades responsible for the transcription of AP-1 and 
NFkB, while ionomycin causes a release of intracellular calcium stores resulting in transcription of NFAT. Thus, 
treatment with both PMA and ionomycin upregulates all three transcription factors required for successful activation and 
expression of IL-2Rα and IL-2. 
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conjugates. In addition, PEGylation strategies have been shown to both minimize nonspecific 
interactions in cellular imaging applications [9] as well as extend clearance rates for in vivo 
imaging applications [10].  
In this paper we examine the feasibility of using QDs as nanoprobes of T cell signaling 
events with the intention of demonstrating the benefits of incorporating QDs as a major read-out 
component of a proposed T cell based cell-signaling platform.  To date, there have been a 
limited number of imaging applications which interrogate a dynamic cellular response utilizing 
QDs, despite their improved photostability. An initial dynamic imaging application employed 
nontargeted, endocytic loading of QDs into both mammalian and D.discoideum cell lines and 
confirmed no deleterious effects on cellular physiology [7].  Single-quantum dot tracking 
methods have since been used to elucidate diffusion dynamics of glycine receptors in the 
neuronal membrane over time frames ranging from seconds to minutes [11]. More recently, 
QDs were used to demonstrate retrograde transport of epidermal growth factor receptors and 
track their subsequent endosomal trafficking [12]. Peptide-conjugated QDs have also been used 
intracellularly, following transfection, for imaging nuclear targets allowing visualization of the 
transport of the QDs from the cytoplasm to the nucleus [5]. It is apparent, given their unique 
optical properties, that QDs can ultimately allow for unprecedented temporal resolution for 
imaging dynamic cellular processes. Thymocytes (T cells) are the major signal transducers of 
the adaptive immune response in mammalian systems. In the presence of a perceived threat, T 
cells undergo a process of activation and proliferation to coordinate an antigen specific immune 
response. Cell surface expression of the cytokine receptor interleukin-2 receptor- (IL-2R), as 
well as secretion of the cytokine interleukin-2 (IL-2), in T cells is widely used as an indicator of T 
cell activation. Figure 1 illustrates the major signaling pathways leading to IL-2 and IL-2R 
production. Successful engagement of the T-cell receptor (TCR) by antigen presenting cells 
(APCs) results in a cascade of intracellular events including the DAG (diacylglycerol), IP 
(inositol 1,4,5-triphosphate), and MAPK (mitogen-activated protein kinase) pathways. Activation 
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of phospholipase C PLC by adaptor proteins and ZAP-70 results in the cleavage of 
phosphatidylinositol 4,5-bisphosphate PIP to produce IP and DAG. IP binds to the endoplasmic 
reticulum and releases calcium stores, activating transcription factor NFAT (nuclear factor of 
activation in T cells), which then moves to the nucleus.  The recruitment and activation of 
protein kinase C (PKC) by DAG [13] have been shown to be integral to the activation of NFkB 
(nuclear factor kappa beta) [14] and AP-1 [15], [16]. 
Alternatively, T cell activation can be chemically induced in vitro by treatment with 
phorbol myrastoyl acetate (phorbol ester or PMA) and ionomycin, which act together to 
upregulate NFAT, NFkB, and AP-1 [17]. Once in the nucleus, the transcription factors NFAT, NF 
B, and AP-1 act in concert to coordinate the activation of several genes involved in host defense 
and inflammatory responses, including production of IL-2 and expression of IL-2Rα.  This high 
level of complexity and discriminatory ability within the signaling pathways of T cells not only 
allows these cells to be highly effective for mediating immune responses against novel 
pathogens, but may also permit the cells to be utilized as biosensors to gain insight into 
methods of detection, prevention, and treatment for biological warfare agents.  
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We believe that construction of a detection system with the ability to sense novel 
pathogens of both known and unknown pathogenesis can be accomplished by utilizing T cells 
as biosensors and taking advantage of the discriminatory power of their diverse intracellular 
signaling pathways. Previous studies support the feasibility of this premise as both anthrax toxin 
[18] and immunomodulatory agents [19] have been shown to suppress T cell activation with a 
significantly varied response on cytokine production levels. We are currently developing 
platforms to study signaling dynamics of single T cells and other cells by utilizing technology 
that allows the simultaneous detection of multiple signals in live cells [20]. It is desirable to 
detect signaling on an individual cell basis to avoid averaging out either rare but important 
signaling events or spatial and relational correlations of signaling events with regard to the 
overall signaling cascade. Incorporation of QDs in this platform will ultimately allow for the 
interrogation of multiple pathways given their narrow fluorescent emission spectra, while the 
inherent brightness of QD probes provides an improved chance of detecting the limited amounts 
of cytokine production at the level of a single cell. Finally, their intrinsic photostability permits 
 
Figure 6.  Time course of IL-2Rα expression. Bright field overlay (top) and QD fluorescence (bottom) images of Jurkat cells 
labeled with anti-IL2Rα-conjugated 655 QDs at different time points subsequent to activation with 10 M PMA and 4 M 
ionomycin. Green fluorescence in the overlaid images indicates nonviable cells using YOPRO-1 (Molecular Probes) cell 
viability stain. An increase in QD fluorescent intensity is observed from: (A) unactivated cells to cells activated for (B) 24 h 
and (C) 48 h indicating an increase in IL-2Rα expression. By 72 h (D) most cells have internalized IL-2Rα for lysosomal 
degradation and fluorescent intensity has correspondingly dropped off. 
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further investigation into the temporal dynamics of receptor expression and subsequent 
localization following expression. 
 
 
Results & Discussion 
Representative fluorescent 
images obtained from the 0, 24, 
48, and 72 h time points are 
illustrated in Figure 2. Unactivated 
cells [Figure 2(a)], which do not 
express IL-2Rαand serve as a 
negative control, show minimal 
nonspecific fluorescent 
interactions.  Receptor expression 
and, correspondingly, fluorescent 
intensity increase from 24 to 48 h 
and then drop off following 48 h. 
This decrease in fluorescent 
intensity is consistent with the 
expected wax and wane of IL-2R 
expression as the receptor is 
internalized upon engagement of 
secreted IL-2 for lysosomal 
degradation [13]. Additionally, 
internalization of the IL-2  IL-2R 
 
Figure 7.  Quantification of IL-2 and IL-2Rα response. (A) FACS 
analysis of anti-IL2R-conjugated QD fluorescence at selected 
points subsequent to activation. Minimal background fluorescent 
intensity is observed for: (a) unactivated cells compared to (b) 
those cells activated for 48 h which exhibit a large increase in 
fluorescent intensity per cell. This increase correspondingly drops 
off by 72 h (c) with only a small population still exhibiting increased 
fluorescence. (B) Average fluorescent intensity per cell obtained 
from fluorescent images using Metamorph image analysis software 
provides a graphical representation of the time course of receptor 
expression. Background subtracted fluorescent intensities were 
averaged over all viable cells imaged throughout the time course 
of one activation experiment. Error bars represent one standard 
deviation of the mean. (C) Quantification of IL-2 production by an 
ELISA provides verification of activation. IL-2R acts to clear IL-2 
from the supernatant initially, but decreased expression of IL-2R 
allows for an accumulation of IL-2 concentration at later time 
points. 
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complex acts in an autoregulatory manner to down-regulate further transcription of IL-2R, further 
decreasing receptor expression and attenuating the T cell’s IL-2 responsiveness [21]. FACS 
analysis provided confirmation of receptor expression and subsequent internalization [Figure 
3(a)]. Minimal fluorescence is observed for unactivated cells (a) and by 48 h (b) most cells have 
shifted to higher fluorescent intensity, which correspondingly drops off by 72 h (c) for all but a 
small number of cells that remain activated. A graphical representation of the relative 
fluorescent intensity per cell throughout the entire time course of activation was obtained by 
fluorescent image analysis using Metamorph software package [Figure 3(b)].  Since activation 
is also accompanied by secretion of IL-2, analysis of the supernatants from each time point by 
means of an IL-2 ELISA provided verification of successful activation [Figure 3(c)].  
Initial examination of the IL-2 ELISA data seemed to indicate a delayed response, as IL-
2 secretion is expected to coincide with IL-
2Rαexpression. However, since IL-2R acts to clear 
secreted IL-2 from the  supernatant, accumulation 
of IL-2 in the supernatant is only observed after a 
significant portion of the expressed IL-2R has been 
internalized, resulting in a sharp spike following the 
48 h time point. Thus, the IL-2 ELISA results 
confirm activation of the T cell populations by PMA 
and ionomycin. 
Confocal microscopy provided direct 
evidence of receptor internalization subsequent to 
expression and anti-IL2Rα–QD labeling (Figure 4). 
Cells that had been activated for 72 h were labeled 
as before with 10 nM anti-IL2Rα-conjugated QDs for 30 min. Following centrifugation, the 
 
Figure 8.  Receptor localization subsequent to 
QD labeling. Jurkat cells activated with PMA 
and ionomycin for 72 h were labeled with anti-
IL2R conjugated 655 QDs. Cells were fixed: 
(A), (B) immediately following QD labeling and 
(C), (D) 24 h after labeling. Confocal images 
(A) and (C): center slice views; (B) and (D): 
orthogonal views of the z-stack) indicate only 
membrane associated QDs for the cells fixed 
immediately following labeling. Cells fixed 24 h 
later, however, have clearly internalized at 
least a portion of the QD conjugates. 
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labeled cells were resuspended in fresh media from which a small population of cells were 
immediately fixed with 4% paraformaldehyde on poly-L-lysine coated glass slides and mounted 
with Aqua PolyMount (Polysciences Inc.) for confocal microscopy. The remaining cells were 
allowed to remain in culture for an additional 24 h before fixation and mounting. Confocal 
images of cells fixed immediately after labeling [Figure 4(a)–(b)] show membrane associated 
extracellular labeling, while cells that have been allowed to remain in culture subsequent to 
labeling [Figure 4(b)–(c)] demonstrate internalization of the QDs (Panels A and C are the 
center-slices from the z-stack of confocal images, while panels B and D provide orthogonal 
views of the XZ and YZ planes). This indicates that the QD-receptor interaction is sufficiently 
strong as to undergo internalization, and that the relatively bulky QD probe does not prevent this 
internalization. 
 
 
Conclusions 
We have demonstrated controlled activation of populations of Jurkat T cells and shown 
that the dynamics of receptor expression can be monitored using antibody conjugated 
fluorescent QD probes. Incorporation with a microfluidic platform capable of isolating and 
maintaining nonadherent cells, currently being developed in our group, will allow these time 
course studies to be performed in real time on thousands of individual cells in a massively 
parallel format. Additionally, other signaling pathways can be simultaneously monitored in a 
similar manner by varying the emission wavelength of the QD probes and targeting these 
probes to other relevant membrane associated receptors. Future experiments will address 
simultaneous detection of multiple cell surface targets in order to more accurately portray the 
signaling state of the cell. In addition, it may prove to be beneficial to compare the brightness of 
these QD conjugates to fluorophores traditionally used for low expression applications, although 
the improved sensitivity of QD probes has been demonstrated extensively. Furthermore, we are 
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currently working on methods to use QDs intracellularly and obtain functional information of 
earlier events occurring within the signaling pathways that may be used in discrimination or 
prediction of cellular response to toxins. Ultimately, QDs will be used as nanoprobes to aid in 
the detection and discrimination of toxin exposure in T cells. The effect of toxin exposure on 
expression dynamics will provide insights not only into the toxin exposure itself, but also provide 
information on the method of pathogenesis as well as treatment. 
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CHAPTER III 
 
MACRO TO NANO: A SIMPLE METHOD FOR TRANSPORTING CULTURED CELLS FROM 
MILLILITER SCALE TO NANOLITER SCALE 
 
Abstract 
 
We describe simple procedures that address the long-standing problem of introducing 
efficient introduction of cells and cell culture media into microfluidic devices using 
polyetheretherketone (PEEK) tubing and Hamilton gastight syringes. Suspension or adherent 
cells grown in cell culture flasks are extracted directly from the centrifuge pellet into the end of 
the PEEK tubing by aspiration. The tube end is then coupled to pre-punched channels in the 
polydimethylsiloxane (PDMS) microfluidic device by friction fitting. Depression of the syringe 
plunger expels the cells into the microfluidic device seconds following aspiration. The gastight 
syringes and PEEK tubing with PEEK fittings provide a noncompliant source of pressure and 
suction with a rapid response time that is well suited for short term intra-microfluidic cellular 
studies. The benefits of this method are its simplicity, modest expense, and the short 
preparation time required for loading appropriate numbers of cells. 
 
Introduction 
An often cited obstacle to widespread use or commercialization of microfluidic 
BioMicroElectroMechanical (BioMEMS) devices is the “world-to-chip”[1] or “macro-to-micro”[2] 
problem of how to introduce samples from milliliter sized volumes into the micro and nanoliter 
volumes of microfluidic devices. This problem is characterized by low Reynold’s number perfusion 
within a noncompliant, very small-volume, high surface-tension device that is resistant to flow. The 
world-to-chip problem is compounded in the case of cellular studies by an increased cellular 
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volume fraction inside the device and a more rapid auto-toxification of the cellular 
microenvironment by metabolic activity of the cell.  We have approached this challenge by noting 
the similarity to the requirement for input impedance matching for maximum power transfer in the 
design of electronic equipment[3]. A driving circuit having lower or higher impedance than a load 
circuit will result in less than optimal power transfer.  Input impedance matching of test circuitry is 
required for accurate control and measurement of electronic circuits. For microfluidic circuits, the 
surface tensions, capacitances and resistance to flow must be considered for high fidelity control 
of the fluid flow within the device. Several good solutions to this problem have been put forth[4-
15], but most either require specialized microfabrication or are limited to specific assays and are 
inappropriate for cellular studies.  Here we describe an inexpensive and simple method for 
accessing, loading and controlling micro and nanofluidic devices for short to long term cellular 
studies. 
 
Cell Density 
The study of cultured cells requires long term containment and nourishment of primary and/or 
immortalized cell lines[16]. The cells under study are usually kept in environmentally controlled 
incubators at bulk concentrations of approximately 1x106 cells/ml or 1 cell per nanoliter or less in 
container sizes of 5 to 50 ml.  For short duration experiments lasting minutes to hours, smaller 
volumes may be extracted from the bulk containers with pipettors into vials of approximately 1 ml. 
At these concentrations, a cell occupies one out of every 1000 possible positions in a suspension 
of cells with the balance being pure media, assuming a spherical cell with 5 m radius and 
approximately 1 pL volume. Since adherent cells are often separated from their substrate and 
released into solution by an enzymatic digestion (i.e. trypsin) for transport or splitting, they may be 
assumed to exhibit roughly the same volume distribution. 
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Microfluidic devices for cellular studies are essentially two-dimensional flow chambers, often with 
vessel heights on the order of one cell diameter. The sparse cellular volume fraction of macro cell 
culture preparations leads to long loading times of microfluidic devices since every cell is not 
closely packed with neighboring cells. The cell-cell separation within the device is determined by 
the volume fraction of cells in the loaded media and a typical 650 × 870 micron field of view from a 
wide field microscope provided by a 20X objective will contain only 14 cells when loaded with 
media containging suspended cells from a macro culture vial. Integrated microfluidic filters may be 
used to help retain the cells that arrive early until later cells appear, but this is accomplished at the 
expense of time and is not always effective since cells are deformable, subject to mechanical 
damage, and tend to squeeze through small gaps in the filters. 
 
Flow Control and Switching 
The instantaneous fluid velocity within a microfluidic device with a chamber height of 
approximately one cell diameter is sensitive to seemingly mild sources of perturbation such as 
temperature, evaporation and mechanical jostling of supply tubing. The resistance of the device is 
often very high and compliance is low. Proper coupling of the fluidic resistance and capacitance of 
the input apparatus is necessary for good flow control. Tubing, fittings and syringes that are 
relatively noncompliant in the macro world must be re-examined for their ability to interface with 
fluidic channels of sub-nanoliter volumes. To realize the full advantage that microfluidic systems 
offer in terms of cellular microenvironment control, the driving system should be capable of rapid 
flow adjustments and switching between different flow sources as well as excellent absolute flow 
control. We have found that ordinary silicone based tubing and plastic syringes commonly used in 
the lab are far too compliant to supply microfluidic devices except in cases of steady-flow and 
slow flow switching. It is also advantageous to have the capability of switching between many 
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sources of flow in a single experiment without being limited by mechanical or stearic hindrances of 
large diameter tubing and syringes. 
 
Transit Time 
Finally, transit time of reagents from the macro to the micro world becomes an important 
consideration when conducting cellular experiments inside the microfluidic device. In many cell 
biology studies it is desirable to introduce agents sequentially such as a primary antibody, 
secondary antibody and fluorescent marker in an immunofluorescence experiment, or putative 
agents in a drug discovery screening. When switching from normal media to media containing a 
bioactive agent, it becomes increasingly important for a rapid effect in the cell chamber as more 
agents are included in a single experiment. Small volume microfluidic drivers such as the glass 
syringe/PEEK tube system described here enable the conservation of expensive reagents and 
reduce the transit time into the chamber containing the cells, which increases data throughput by 
minimizing the duration of experiments. Indeed, one of the great promises of microfluidic “lab on a 
chip” technology is high throughput, data-dense studies. 
For these reasons we have examined the use of small-volume glass body Hamilton Gastight 
syringes (Hamilton Company 80920) and polyetheretherketone (PEEK) tubing and fittings 
(Upchurch Scientific) as flow drivers for microfluidic structures. We developed the techniques 
described in this technical note for loading cells into microfluidic cell-trapping devices of 
approximately 100 nanoliter overall volume from the condensed cell pellet. Our goal is to 
decrease reagent waste, decrease the need to seperate cells from media on-chip, and increase 
experimental throughput by minimizing delays due to sparseness of cells. 
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Methods 
Primary human T cells were obtained from healthy donors using separation methods described 
elsewhere[17]. The T cells were stored in liquid nitrogen in aliquots of approximately 1x106 cells 
per tube. For experiments, the cells were thawed rapidly, washed and re-suspended in RPMI 
complete media in a 100 ml flat bottom culture flask and maintained at 37oC and 5% CO2 in an 
incubator for 4-5 days. During this time, precise volumes of media and cells were removed by 
sterile pipetting from the culture flask and 
dispensed into 1.6 ml microcentrifuge tubes.  
Centrifugation of the microcentrifuge tube at 
1000×G for 1 minute caused the formation of a 
cell pellet near the bottom of the tube. 
Positioning the PEEK tube end near or within 
the pellet (see Figure 9) during retraction of the 
syringe plunger allowed us to harvest cells by 
gentle aspiration into the PEEK tubing. We 
routinely use this aspiration method in our laboratory with cell pellets of 10,000 or more 
suspension or adherent cells of various types and sizes. After aspiration, the end of the PEEK 
tubing is immediately placed into a pre-punched hole in the PDMS device (see Figure 10).  To 
avoid bubble formation at the junction of the PEEK tubing and the fluid within the microfluidic 
device, we first make sure the inlet channel to the device in completely filled with media.  We then 
push media through the PEEK tubing using the syring pumps until we observe droplet formation 
on the end of the tubing.  The droplet on the end of the tubing is then joined with the media on the 
surface the device entrance port to form an air-tight seal around the tubing.  The tubing is then 
PEEK Tube OD
PEEK Tube ID
(60 microns)
 
Figure 9. An inverted microscope image of a 
500,000 cell pellet in the bottom of a 1.6 ml 
microcentrifuge tube during aspiration. Red overlay: 
PEEK tube end, Yellow overlay: Direction of cell 
motion into tube. 
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inserted into the channel without having trapped any air in the process which could cause 
catastrophic issues later in the 
experiment.   
The entrance port itself is punched with 
sharpened 0.25 gauge needle stock 
(McMaster-Carr #75165A686). Typically 
our PDMS structures are 2-5 mm thick 
leading to 2-5 mm of contact between the 
outer surface of the PEEK tube and the 
inner PDMS surface of the punched hole. 
We have found this friction fit is more than adequate to support flow rates of 0-3000 nl/min. Due to 
the low dead volume and low compliance of the system, cells begin appearing in the channels of 
the device immediately upon coupling of the tube to the device, or at time delays selectable by 
aspiration of a leading plug of pure media.  
To guage the effects of aspiration and residence time in the PEEK tubing on cell viability, 
controlled studies were performed comparing residence times from 0 minutes (no residence in the 
PEEK tubing) to 90 minutes. During experiments, great effort is taken to keep cell residence time 
within the tubing to a minimum and typically does not exceed 15 minutes.  As shown in Figure 4, 
no appreciable decrease in cell viability was noted in samples that were resident in the tubing up 
to 30 minutes. Furthermore, long-term experiments performed using cells transferred to devices 
using this method reveal that both Jurkat and primary CD4+ T cells remain viable for more than 
24 hours indicating that PEEK tubing aspiration does not induce apoptosis (data not shown). 
Taken together this suggests that this aspiration method is well suited for cellular applications.   
 
 
A
B
1-3
minutes
Cell culture or 
biopsy prep
Microfluidic 
device
 
Figure 10. (A) Aspiration of cells from the pellet in a 
microcentrifuge tube (B) Loading of cells into PDMS 
microfluidic device using a simple friction-fit coupling 
between PDMS and PEEK tubing. Normally actuation of the 
syringe plunger is controlled with a syringe pump. 
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Discussion 
We have loaded microfluidic devices with both 
adherent and suspension cells using our 
technique for aspirating cells from the 
centrifuge pellet. The small-bore, low 
compliance tubing enables the suction of high 
cell-fraction media from the pellet and 
immediate loading into a perfused microfluidic 
device. We have used this aspiration method 
with a variety of cells including the Jurkat T cell 
line, primary T and B cells, dendritic cells and 
adherent cell lines. 
The low compliance PEEK tubing and glass body syringes with syringe pumps allow us to control 
absolute flow and switch between many flow sources very rapidly with short delays. The small 
bore of the PEEK tubing and the ease with which it can be cut and bent allow the access to the 
high density cell centrifugation pellet. Aspiration of cells from the pellet with this setup leads to 
very rapid transition from cell culture volumes and concentrations to microfluidic volumes and 
concentrations, with the whole technique being (including centrifugation) accomplished in 3-5 
minutes.  The small outside diameter and 60 µm inside diameter and the easy deformability of the 
PEEK tubing allows interconnection of microfluidic devices with the output from one device 
providing input to a downstream device, etc. (See Figure 11)  
 
Figure 11.   Image of a multi-device stage insert containing 
two devices interconnected with PEEK tubing. 
Interconnection volume is approximately 100 nanoliters. 
Inset A: close-up of device. Inset B: close-up of 300 m 
tubing to be inserted into punched hole. 
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Figure 12.  Graph illustrating the percentages of live Jurkat T cells 
remaining following various lengths of time housed inside PEEK 
tubing after aspiration from pellet.  Negative control samples 
consist of cells taken straight from cell pellet following 
centrifugation.  Cells were incubated in 70% water/media solution 
for 5 minutes to obtain positive control viability data.  The 
remaining time points were obtained after allowing aspirated cells 
to  reside within PEEK tubing, then released onto a Petri dish with 
media containing yopro-1 for imaging.  No noticeable decrease in 
viability occurs prior to 30 minutes while more that 85% of cells 
remain viable following 90 minute incubation.  Error bars indicate 
+/- one standard deviation. 
Using these methods, we have 
supplied devices with 3-5 different 
perfusion sources routinely and can 
switch rapidly between supplies or 
any combination or mixture of 
supplies. We could potentially 
achieve a dozen or more supply 
lines in a single device using these 
small, deformable tubes.  Finally, 
we have extracted cells from 
microfluidic devices back into the 
PEEK tubing where they may be 
re-dispensed into macro cell culture 
vials for possible long-term 
traditional culture in incubators. 
 
Conclusions 
The methods described here offer four advantages over other methods for conducting cellular 
studies within microfluidic devices: 1) Small volume flow drivers conserve samples and 
experiment time; 2) non-compliant drivers lead to fast flow response and rapid switching; 3) small 
tubing bore and outside diameter facilitates the aspiration of cells from centrifuge pellets; 4) the 
low expense, small size and deformability of the PEEK tubing facilitates the interfacing of 
microfluidic devices with many different perfusion sources.  
Rigid, low-compliance, low dead volume perfusion systems reduce the time required to set up cell 
studies in microfluidic devices. Aspiration from the centrifuge pellet as demonstrated here enables 
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rapid access to sparse cells in macro cell culture dishes. Many independent perfusion mixtures 
may access the same microfluidic chip and any combination of switching or mixing may be rapidly 
accomplished during an experiment. Interconnection of separate microfluidic devices is easily 
achieved with PEEK tubing with very low transit time between devices. Cells that have been 
studied or treated within he device can also be easily off-loaded from the device and return to 
conventional cell culture flasks using this system if sterility is maintained throughout the 
experiment. 
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CHAPTER III 
 
MICROFLUIDIC PLATFORM FOR REAL-TIME SIGNALING ANALYSIS OF MULTIPLE 
SINGLE T CELLS IN PARALLEL 
 
 
Abstract 
T cells are a vital component of the adaptive immune response in humans.  
Understanding the signaling events that determine reaction versus anergy in these cells is 
critical in developing successful methods of diagnosis, treatment, and prevention of disease.  
Studying single cell dynamics over time reveals rare events that might be averaged out in bulk 
experiments, but these less common events are undoubtedly important for an integrated 
understanding of a cellular response to its microenvironment  The nanophysiometer is a self-
contained unit fabricated of optically transparent, bio-inert PDMS on glass and designed to 
maintain non-adherent cells in a microfluidic environment.  In this report we validate the 
microfluidic nanophysiometer as a platform to facilitate the study and manipulation of multiple 
single T cells in parallel.  As T cells are injected into the cell culture media perfusing the 
nanophysiometer, they are passively trapped in one of 550 18 µm×18µm×10µm PDMS, bucket-
like structures as they pass through the cell trap region.  Cell viability analysis revealed that at 
flow rates of 100 nl/min, more than 70% of CD4+ T cells, held in place using only hydrodynamic 
forces, remained viable following 24 hours in the nanophysiometer.  We then demonstrate the 
ability to activate T cells within the nanophysimeter using chemical, antibody, and cellular forms 
of sitmulation.  Cytosolic calcium transients were recorded for each form of stimulation.  
Statistical analysis of T cells from a single stimulation experiment reveal the power of this 
platform to distinguish different calcium response patterns, an ability that might be utilized to 
characterize T cell signaling states in a given population. 
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Introduction 
T cells play a central role in cellular mediated adaptive immune responses as they are 
highly involved in recognizing and responding to foreign/dangerous antigens.  Hence, 
deciphering the signaling pathways governing T cells in activity is of utmost importance 
understanding the adaptive immune response as a whole.  While the intracellular signaling 
pathways the govern T cell response are some of the most intensely studied, the intricacies of 
many signaling mechanisms remain unclear.  Conventional cell culture methodologies involve 
analyzing bulk responses from million of T cells which may average out key, rare signaling 
events important in the progression of a successful immune response[1].    Fluorescence 
activated cell sorting (FACs) yields single cell data, but cannot provide information on the 
temporal cellular signaling dynamics[2].  In order to reliably monitor single T cells over time in cell 
culture dishes, antibodies or other adhesive proteins are required to tether the cells to the 
surface.  This, of course, result in the initiation of unwanted intracellular signaling cascades that 
alter the signaling state of the cells.  Thus, there is a need for a new type of experimental 
methodology that facilitates the analysis time-resolved signaling dynamics in individual T cells. 
The utilization of microfluidic devices for cellular applications has exploded over the past 
10 years with the promise of lower production and reagent cost, tighter control of experimental 
paramenters, and quicker reaction times along with reduced diffusion times compared to 
traditional cell culture techniques[1;3;4].  The latter point opens the possibility of interrogating 
cellular activities that occur in time scales to quick to observe with conventional techniques[5].  
Flexible and relatively easy fabrication allows incorporation of more complicated microfluidic 
designs including valves, pumps, and switches which enhance the manipulative ability of the 
cellular micro-environment[6-8].  Furthermore, culturing cells in a constant flow-thru environment 
is arguably more physiologically relevant than maintaining cells in a relatively large, stagnant 
pool of media as done in conventional cell culture.   
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The ability to maintain mammalian cells for extended periods of time has been 
demonstrated in adherent cell lines[9-11].  Cells readily adhere to the glass surface (sometimes 
functionalized to promote adhesion) and are able to be studied individually or en mass.  When 
working with suspension cells, however, the same adhesion problem that plagues traditional cell 
culture methods is true for microfluidics as well; methods to adhere cells to a surface (antibodies 
or adhesion proteins) will induce undesired intracellular signaling pathways that alter the state of 
the cell.   
One solution to this problem is to use suction to hold a cell in a “trap”, which has been 
demonstrated to be very effective with cardiac myocytes[12-14].  However, T cells, one of the 
main focuses of this research, are extremely small compared to cardiac myocytes with 
diameters of naïve T cells ranging between 5-7 µm.  The diameter of the suction channels 
would ideally be much smaller than the diameter of the cell, but this aspect ratio is nearing the 
resolution limit for out current fabrication facilities.  Furthermore, T cells are highly deformable 
and sensitive to pressure.  Suction easily lyses these cells and those that remain intact are 
destined for apoptosis.  Thus, for analysis of T cells, it is essential to have a passive trapping 
process.   
A truly passive trapping mechanism was developed by Wheeler et al[15].  A clever 
device design incorporating on-chip valves allowed high precision control of fluid flow such that 
individual T cells could be directed into a bucket-shaped chamber.  Once trapped, the intricate 
hydrodynamic controls allowed the cell to be directly addressable by dyes, stimulants, or lysing 
agents.  However, the design was arranged such that only a single cell was trapped and 
interrogated during a single experiment.   This is highly inefficient for collecting information 
concerning a population of T cells.  To maximize the quantity and quality of data extracted from 
a given experiment, it is desirable to have many (hundreds to thousands) individually trapped 
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and fluidically addressable T cells within a single microfluidic platform.  To our knowledge, such 
a platform for analysis of T cells does not yet exist.   
.  As such, we herein report the development and 
validation of a novel microfluidic platform, the multi-trap 
nanophysiometer, which addresses these needs.  We 
demonstrate the ability to utilize this platform passively capture 
primary CD4+ T cells (TCs) using only hydrodynamic forces as 
well as maintain the cells within the microfluidic the device for 
more than 24 hours.  Furthermore, we show that in this 
microfluidic environment we are able to stimulate calcium 
signaling in TCs using chemical, antibody, and cellular 
methods.  Data collection and analysis can be completely 
automated to sort the resulting calcium traces.  The multi-trap 
nanophysiometer enables the analysis and classification of individual cells based on their 
dynamic, phenotypic response to stimuli, and requires the use of tiny sample volume, such as 
might be obtained by a finger stick blood sample, and thus must be considered as a 
complementary technology to flow cytometry. 
A schematic of the microfluidic multi-trap nanophysiometer is shown in Figure 1.  This 
platform is a self-contained unit fabricated of optically transparent, bio-inert PDMS on glass and 
designed to maintain non-adherent cells in a microfluidic environment.  Cells are introduced into 
one of the inlet ports using computer-controlled micro-syringe pumps[16].  As cells flow through 
the trap region, cells are passively trapped in one of 440 18 µm×18 µm×10 µm PDMS, bucket-
like structures (see Figure 2 for close-up view of cell traps).  Fluid flow rate is optimized such 
that cells remain in traps and receive necessary nutrients while shear stress and waste 
accumulation are minimized.  This provides a method of quickly sequestering cells into 
individually addressable compartments without using any type of adhesive agents, such as the 
 
Figure 13.  Schematic of 
microfluidic nanophysiometer. 
The device is constructed of 
PDMS and plasma-bonded to a 
glass coverslip 
Fig1 
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normally used cell surface antibodies, poly-l-lysine, or fibronectin, which can themselves induce 
unwanted intracellular signaling cascades.  Furthermore, only relatively small quantities of cells 
(aliquots as small as 1000 cells), media (~100s of microliters for long-term experiments), and 
other reagents are required to obtain data on hundreds of single cells in parallel, resulting in 
decreased labor and material costs.  The small size of the device decreases the time required to 
scan the entire cell trap region during automated, high-magnification microscopy. 
 
Materials & Methods 
 
Experimental Setup 
All experiments were performed using an Axiovert 200 microscope (Carl Zeiss), which 
was equipped to facilitate long-term maintenance of cells during experiments, as shown in 
Figure 2.  A plexiglass incubator enclosed the microscope such that the temperature was 
consistently maintained at 37oC.  The multitrap nanophysiometer chip was enclosed within a 
petri dish (Fisher Scientific, Hampton NH) with holes machined in the bottom to allow 
microscope viewing, as well as slots in the top for polyethyletylketone (PEEK) tubing passage.  
In addition, a port was drilled in the side of the dish to allow tubing connected to a gas supply 
such that a constant flow of 5% CO2 and 95% air was delivered to the petri dish.   
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To minimize evaporation, 3 to 4 layers of filter paper (Whatman, Florham Park NJ) 
saturated with distilled H20 surrounded the device inside the petri dish.  The motorized 
microscope stage, image acquisition, focus, and filter settings were controlled using Metamorph 
software (Molecular Devices, Downington PA).  Syringe pump flow rates were also under 
computer control, utilizing software developed by VIIBRE researchers.  Images were obtained 
with the electrically cooled CoolSNAP HQ CCD camera (Photometrics, Tucson AZ).  
 
DEVICE
Glass
PDMS
Flow
MS
Flow
l ss
Inlet
Ports
Exit 
PortCell Traps
 
Figure 14.   Schematic illustrating the standard experimental setup for the multi-trap 
nanophysiometer. 
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Cell Culture 
Primary human CD4+ T cells and dendritic cells (derived from human monocytes) were 
generously provided by the lab of Derya Unutmaz following isolation and purification from 
human blood donors [17].  Primary CD4+ T cells were thawed from liquid nitrogen aliquots 
(5×105 cells/vial) 24 hours prior to use and cultured using sterile technique in RPMI 1640 cell 
culture media (ATCC, Manassas VA) supplemented with 10% fetal bovine serum (ATCC, 
Manassas VA) and 10µg/ml Ciprofloxacin (Mediatech, Herndon VA).  Dendritic cells were 
derived by incubating primary human CD14+ monocytes with 20 ng/ml IL-4 and 100 ng/ml GM-
CSF for 4-6 days [17;18].  Mature dendritic cells were generated following 24-hour incubation 
with 10 ng/ml LPS [17;18].  All cells were incubated in a sterile environment maintained at 37oC, 
complete with 5% CO2 and 95% humidity. 
 
Microfluidic Cell Loading 
Cell loading followed methods developed by our lab and described in greater detail in a 
previous publication [16].  Cells were centrifuged to a pellet at 5000 rpm for 1 minute in a 1.5 ml 
eppendorf tube (Fisher Scientific, Hampton NH) 
which were then mounted on a glass slide with 
cellophane tape for microscope viewing.  Once 
the pellet was located using the microscope, 50 
µm I.D. PEEK tubing (Upchurch, Oak Harbor 
WA), connected to 50 µl gas-tight syringe 
mounted on a computer-controlled syringe pump 
(Harvard Apparatus, Holliston MA), was guided to 
the cell pellet.  Cells were then aspirated directly 
into the PEEK tubing using the syringe pump set to withdraw fluid at a flow-rate of 0.5 µl/min.  
Figure 15.  Macro cell culture to micro cell 
culture in microfluidic devices. Use of ultra 
small bore tubing to aspirate controllable 
volumes of high cell-density and seed into 
device. 
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The tubing was then inserted to a loading channel of a device pre-cleared with sterile media.  
This cell loading procedure is illustrated in Figure 3.  Once all inputs were connected to the 
device, the pump controlling the cell channel was set to a forward flow rate of 100 nl/min for 
passive loading of cells into the traps as they traverse the device.  Unless otherwise noted, the 
media used to perfuse the device and the cells contained within consisted of RPMI 1640 
supplemented with 10% FBS and 10 µg/ml ciprofloxacin. 
 
Cell Viability Assay 
Approximately 5×104 primary human CD4+ T cells were loaded with a cytosolic calcium 
indicator dye by incubating the cells in a solution of 5 µM rhod-2 AM (Invitrogen, Carlsbad CA) 
for 30 minutes at 37oC.  Cells were then loaded into the microfluidic device as described 
previously.  The perfusing media was supplemented with 1.8 mM CaCl2 (Sigma, St. Louis MO) 
to mimic normal in vivo calcium levels [19].  A second syringe was prepared containing normal 
cell culture media supplemented with 1 nM Yopro-1 viability indicator (Invitrogen, Carlsbad CA).  
Using Metamorph software, the microscope was programmed to obtain DIC (bright field), FITC 
(Yopro-1), and TRITC (rhod-2) images for 5 fields of view spanning the cell trap region every 30 
minutes for 24 hours.  Pump control software generated by VIIBRE researchers was 
implemented to switch from the perfusing media to media containing Yopro-1 every 2 hours for 
5 minutes.  Unless otherwise noted, the flow rate was maintained at 100 nl/min.   
 
Cytosolic Calcium Assay 
Release of intracellular calcium stores, an early signaling event in T cell activation, was 
induced chemically, with antibody-coated beads, or by co-incubation with antigen-presenting 
cells.  In all cases, naïve primary CD4+ T cells were first loaded with rhod-2 calcium indicator by 
incubation in a 5 µM solution for 30 minutes at 37oC.  Cells were then loaded into a microfluidic 
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device (pre-cleared with media to remove air bubbles) and perfused with normal culture media 
supplemented with 1.8 mM CaCl2.  Using Metamorph software, the microsope was programmed 
to obtain baseline bright field (DIC or phase-contrast) and TRITC (rhod-2 fluorescence) images 
for 4 to 5 fields of view (FOV) spanning the entire cell trap region of the microfluidic device every 
30 seconds. 
Chemical Stimulation.  A solution consisting of plain culture media supplemented with 
1.8 mM CaCl2, 20 ng/ml IL-2, and 8 µM ionomycin, a known calcium ionophore [20], was 
introduced into an adjacent entrance port.  Calcium release from the T cell endoplasmic 
reticulum was stimulated chemically upon switching perfusate flow completely to the media 
containing ionomycin. 
Bead Stimulation.  Protein A coated microspheres (Bangs Laboratories, Fishers IN) were 
conjugated to anti-CD3 and anti-CD28 antibodies (R & D Systems, Minneapolis MN).  Antibody-
conjugated beads were loaded in the same manner as cells (aspiration from a centrifuged 
pellet) and introduced into the device directly following cell trapping.  Image acquisition was 
begun upon bead introduction and continued for the duration of the experiments as described 
above. 
APC Stimulation. Lipopolysaccharide (LPS), a protein found in the membrane of gram-
negative bacteria, was used to promote maturation of primary human dendritic cells (DCs) 
obtained from the Unutmaz lab.  Prior to loading, the DCs were made immunogenic by 
incubation with 5 µg/ml staphylococcal enterotoxin B (SEB), a superantigen that binds to the 
outer portion of the major histocomplatibility complex (MHC) yielding immunogenic DCs, for 
thirty minutes at 37oC.  DCs were then rinsed with fresh media to remove all unbound SEB.  The 
resuspended cells were then centrifuged to a pellet for cell loading as described above.  TCs 
were trapped first, and then DCs were introduced to the devices.  Image acquisition began upon 
introduction of DCs. 
 59 
 
Image Storage and Analysis 
Due to the large quantity of potential information that can be extracted from a single 
experiment when monitoring hundreds of cells with a variety of fluorescent markers over an 
extended period of time, it was both desirable and necessary to develop an automated analysis 
program.  Metamorph was used to collect images and store them in a stacked format to the 
hard drive.  Analysis of image data was done primarily using Wright Cell Imaging Facility 
ImageJ bundle and Microsoft Excel along with custom written macros.  First, phase contrast and 
fluorescence images obtained at a single time point are aligned and re-indexed using a modified 
routine written by Phillippe Thevanez.  This algorithm calculates the X and Y translation of each 
phase contrast (bright field) image relative to a reference image of the same series and saved 
the data to a file. The resulting translations were applied to the phase contrast and fluorescent 
images together to ensure proper alignment between each image at a given time point was 
maintained. The particle analyzer routines embedded with the WCIF ImageJ bundle were used 
to find the positions of cells in the resulting images, and the mean gray values at these positions 
were recorded to file. 
Microsoft Excel macros were used to segment the data files into trap regions based on 
the XY positions recorded by the ImageJ particle analyzer. A typical field of view contains up to 
85 traps and each trap contains a number of cells to be determined. Segmentation into trap 
regions requires input regarding the total offset of the image since all the microfluidic traps are 
spaced very precisely. Segmentation of individual trap zones into individual cells is more 
complex. Briefly, the first slice which occurred that contained the maximum number (Nmax) of 
putative cells for the time series was selected as a cardinal slice. The positions of each of the 
cells were stored in a 2 x Nmax array. Every time point is then sequentially compared to the 
cardinal time point, and the XY positions of the cardinal time point are updated and replaced by 
the XY positions of each time point weighted by observation. In this way, if a cell is repeatedly 
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found near one particular position (even if it is not found in the cardinal slice) it is weighted 
heavily as a probable cell position in the final analysis. Similarly, if a spurious cell or debris is 
located at a single time point it is weighted less heavily and is less likely to appear in the final 
analysis.  Fluorescence intensities of cells found using this algorithm were automatically plotted 
out in Excel for further analysis.   
 
Cluster Analysis of Calcium Data 
The extracted tracings were automatically sorted or clustered into groups by their 
responses to a given stimulus. Cluster analysis, or unsupervised learning, is a set of statistical 
methods used to identify meaningful or informative subgroups within a dataset. For this study, 
we used hierarchical clustering to identify scales of similarity between T-cells and groups of T-
cells.  A distance metric must be specified to measure the pair-wise similarity between T-cells.  
Each cell's time-series is treated as a vector in a multi-dimensional space, and for this study we 
used the Pearson correlation metric, which is well-suited for measuring differences in shape 
between two curves. 
The clustering algorithm works by creating a pair-wise distance matrix between all cells 
and creating a cluster by merging the pair of cells with the smallest separating distance.  A new 
distance matrix then is created with the unclustered cells and the merged cells, and the process 
is repeated.  The location of the merged cluster can be defined in different ways, among them: 
single linkage, complete linkage, and average linkage (the average of the cell vectors).  We use 
complete linkage, though all methods give similar clusters.   
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Results & Discussion 
 
Device Characterization 
 Before utilizing the microfluidic device for cellular assays, we evaluated the characteristic 
flow profiles within the device and the device’s cell trapping ability.  To visualize the perfusion 
dynamics within the nanophysiometer, alternating aliquots of fluoroscein and water were passed 
through the device at various flow rates.  Results of this experiment are shown in Figure 4.  
Figure 4A illustrates the flow profile of a bolus of fluoroscein through the cell trap region of the 
nanophysiometer at 50, 100, and 250 nl/min (a, b, and c, respectively).  The entire trap region is 
accessed by the dye within 45 seconds of starting the syringe pumps.  Figure 4B quantitatively 
describes the fluorescent images by showing the fluorescence intensity versus time for fixed 
points in the front, middle, and back of the trap region (P1, P2, and P3, respectively).  Finally, 
Figure 4C shows a series of images obtained of a single cell trap during the cell loading 
process.  In this trap, six cells were captured within one minute of cell introduction.  With our 
current cell loading techniques and tight flow control, the trapping efficiency (# traps containing 
cells/ # traps) of these microfluidic devices approaches 100% in each experiment.  Because so 
few cells are used to load the devices (as little as 1000 cells), this platform offers a unique and 
highly economic option for studying rare or costly cell types. 
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The triangular shape of the cell trap region was designed such that the behaviors of cells 
not exposed to cell secretions (cells trapped nearest the inlet) can be compared to those 
trapped nearest the exit, which are exposed to all the secretions of cells trapped upstream.  This 
difference in local environment can be a very useful tool in studying intercellular signaling 
events which are extremely important to immune cell signaling.  T cells are known to employ 
both autocrine and paracrine signaling, such as in IL2 production, in the earliest stages of 
activation [21-23].  Furthermore, Th1/Th2 differentiation is highly dependant on the cytokine and 
chemokine gradients existing in the local surroundings[24-28].  These are only two of many 
examples in which intercellular signals are important in development of immune response.  Both 
the shape and the small volume (~ 25 nl) of the device allows these signals to be studied in 
real-time and without fear of dilution.  In fact, cells downstream may suffer from accumulation of 
signaling agents as well as waste 
products.  This too is important 
information with regards to 
understanding immune cell function 
as the mechanisms that govern T cell 
anergy and apoptosis are of great 
interest to the medical community 
[29-32].  In a single experiment it is 
possible to obtain information on 
cells exposed to an entire spectrum 
of cellular products concentrations. 
 
Cell Environment and Viability 
 In order to reliably utilize the 
nanophysiometer for cellular assays it is important to first validate that T cells are stably 
 
 
 
Figure 16.  Perfusion dynamics and cell loading characteristics of 
the microfluidic nanophysiometer.  (A)Time response and perfusion 
dynamics of the  nanophysiometer at (a) 50 nl/min, (b) 100 nl/min, 
and (c) 250 nl/min. (B) Graphs illustrate the fluorescence versus 
time at points P1, P2 and P3 (shown in the lower right hand corner 
of A). All traps are accessible via flow switching with similar time-
responses at flow rates above 50 nl/min. (C) A single 
representative cell trap within the nanophysiometer during cell 
loading.  Trapping efficiency (# of traps containing cells/# of traps) 
approaches 100% within minutes of introducing cells. 
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maintained within the microfluidic device over time as they are in traditional cell culture 
environments.  The rates of perfusion, consumption of nutrients, and production of waste 
products all affect the viability of cells within the device as well as their ability to respond to 
stimuli.  The following experiments investigate cellular viability and ability to react to ionomycin 
stimulation with respect to perfusion flow rate.   
Since secretion of IL2 and expression of IL2Rα require up to 24 hours following T cell 
activation, both viability and activity (the ability to elicit a measurable calcium transient in 
response to ionomycin exposure) measurements were analyzed following 24 hours of 
incubation within the nanophysiometer.   .  Cell viability was assessed using Yopro-1, a dye that 
fluoresces upon interaction with nucleic acids, which was transiently exposed to the cells every 
two hours.  Cell activity, the ability of the T cells to respond to ionomycin stimulation with a 
measurable cytosolic calcium transient, was tested at the conclusion of the 24 hour experiment 
by perifusing the device with media containing ionomycin.     
 
Figure 17.  Cell viability analysis within the microfluidic nanophysiometer. (A) Schematic 
illustrating the four fields of view that were imaged every 20 minutes.  (B) An example of 
images obtained during the viability experiments.  Cells exhibiting fluorescence due to yopro-1 
staining are dead.  (C) Viability as measured by percentage of cells alive after 24 hours with 
respect to both flow rate and position within the device.  (D) Cellular activity as measured as 
percentage of cells that respond to ionomycin exposure with a measurable cytosolic calcium 
transient following 24 hours within the device.  Results are shown with respect to both flow rate 
and position within the device. 
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Results from the viability experiments are shown in Figure 5.  Four pump flow rates 
were evaluated and it was determined that 100 nl/min is optimal for promoting long-term cell 
viability with nearly 70% of cells alive after 24 hours.  This flow rate was also best in terms of 
cellular activity measurements, with approximately 40% of cells exhibiting a measurable calcium 
response upon exposure to ionomycin 
after 24 hours.  It is unknown whether 
this indicates that the inactive cell 
population (cells not responding to 
ionomycin) that were counted as viable 
(i.e. not stained with yopro-1) were in 
fact in a quiescent state or perhaps the 
early stages of apoptosis.  We are 
currently developing mathematical models describing fluid dynamics within the device as well as 
cellular metabolism to aid in predicting cell viability and activity such that we may optimize 
nutrients, flow rate, temperature, etc. in order to increase the activity of cells during long term 
maintenance within the microfluidic device.  This will be of great importance for long-term 
activation studies monitoring late indicators of activation such as IL-2 secretion or IL2Rα 
expression.  Activation studies focusing on calcium response, however, involve relatively short 
duration experiments as calcium release from intracellular stores typically occurs within seconds 
of proper stimulation.   Short duration experiments are extremely well tolerated by cells with 
greater than 90% remaining viable for up to 12 hours with pump flow rates set to 100 nl/min.   
The triangular shape of the nanophysiometer results in a decrease in linear flow velocity 
as the media traverses the cell trap region.  Figure 6 shows the predicted decrease in flow 
velocity with respect to distance from the cell trap region inlet.  At low flow rates, cells nearest 
the inlet survived better than those farthest from inlet.  We hypothesize that this was due to the 
fact, compared to cells near the exit, that the cells in the front of the device had access to 
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Figure 18.  Graph of the predicted decrease in flow rate from 
inlet to exit of the nanophysiometer cell trap region.  Note that 
cells in the back of the device experience flow rates an  order 
of magnitude less than those close to the inlet. 
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adequate nutrients from the media along with a quicker fluid volume turnover rate which 
facilitated the removal of waste products.  Accordingly, the cells in the back of the device were 
exposed to media not only depleted of nutrients, but also carrying a larger concentration of 
cellular wastes.  The accumulation of cellular waste increases the acidity of the media, which is 
known to cause T cells to become inactive and/or enter apoptosis[33;34].  Cells in general fared 
less well at lower flow rates due the depletion of nutrients by the cells near the inlet, 
compounded by the exposure to cellular waste.  Increasing the media flow rate to 100 nl/min 
increased cell survival by more than three times that found at 50 nl/min (Figure 4C).  At this flow 
rate, the cells throughout the device are exposed to a nutrient/waste concentration ratio that is 
more compatible for long-term survival.  Interestingly, increasing the flow rate to 150 nl/min and 
250 nl/min caused a decrease in cell viability.  In addition to taking care to optimize the 
waste/nutrient ratio cells are exposed to, there is also a factor of shear force impinged on the 
cells by the fluid flow that can also effect viability.  We hypothesize that at the higher flow rates, 
cell death was associated with too high a shear force, resulting in either cell lysis or apoptosis.  
This is supported by the observation that the cells exposed to these flow rates died very quickly 
(within the first few hours, data not shown) of the experiments and the cells near the inlet of the 
device died more quickly than those in the back of the cell trap region. 
While 100 nl/min was still the optimal flow rate for cell activity, the percentage of cells 
responding to the ionomycin challenge approached only 40% (Figure 5D).   
 
Cytosolic Calcium Assay 
 Once we demonstrated that the primary CD4+ T cells could be trapped and maintained 
within the nanophysiometer, we then proceeded to demonstrate that we could activate the 
primary T cells within the device.  We employed three methods of activation: chemical 
stimulation with ionomycin, antibody stimulation with anti-CD3- and anti-CD28-coated 
microspheres, and cellular stimulation using SEB-pulsed, LPS matured, primary human 
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dendritic cells.  Quantitative results of these experiments are shown in Figure 7.  In each case 
we were successful in activating the primary CD4+ T cells as illustrated by the cytosolic calcium 
transients observed using rhod-2 AM Ester calcium indicator.   
The results of the control experiment shown in Figure 7A clearly show that rhod-2 
loaded cells did not exhibit any cyctosolic calcium increases when exposed to plain media.  
Introduction of antibody-coated beads (Figure 7B), ionomycin (Figure 7C), and mature 
dendritic cells (Figure 7D) all resulted in strong calcium responses.  The cyctosolic calcium 
transients induced by antibody-coated beads and dendritic cells are consistent with traces found 
in literature [35;36]. 
 Ionomycin stimulation of T cells resulted in calcium transients whose shape and 
duration differed from more physiologic forms of stimulation.  This illustrates a key strength of 
the nanophysiometer platform in that we were able to observe the individual cell responses to 
 
Figure 19.  Examples of cyctosolic calcium transients, as indicated via rhod-2 calcium dye, in single primary T 
cells exposed to (A) plain media, (B) antibody-coated microspheres, (C) ionomycin, and (D) mature, stimulated 
dendritic cells.  Each trace represents a single cell.  Three traces are shown in (C) to illustrate the three typical 
calcium transient patterns observed when stimulating T cells with ionomycin. 
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the ionomycin from nearly 800 cells and clearly identify three distinct populations of responses 
in a single experiment (as shown in representative curves in Figure 7C).  Automated ImageJ 
and Excel routines were used to analyze fluorescence images of T cells challenged with 
ionomycin.  The analysis found 809 raw fluorescence traces which included 69 duplicates, 195 
truncated curves with insufficient data and 88 flat-lines or unresponsive traces found by 
calculation of the data trend. There were 457 unique traces for use with automated clustering 
analysis, the results of which are illustrated in Figure 8.  A dendrogram plot (Figure 8, left) 
illustrates the distinct clusters of T cells comprising the range of calcium responses to ionomycin 
as determined by the clustering algorithm.  The horizontal axis measures the dissimilarity 
between cells and clusters of cells.  The vertical lines in the diagram tell you the distance 
between the clusters connected by the tree's horizontal lines.  By inspection of the dendrogram 
in Figure 8 one can see that there are three major subgroups of cellular calcium responses to 
ionomycin.  In cluster profiles graphic (Figure 8, right), we plot the individual time-series profiles 
for each of the 457 T cell responses with respect to the group with which they are clustered.  
The distinguishing feature of these subgroups is the fall-time, or time it takes the intensity to 
return to baseline following the initial intensity rise following exposure to ionomycin,  Cluster A is 
comprised of T cells exhibiting a marked increase in fluorescence upon ionomycin exposure 
followed by a sharp drop in fluorescence that falls to below initial baseline fluorescence levels, 
often within a single data point (30 seconds).  Cells within cluster B respond to ionomycin with a 
similar increase in fluorescence intensity, but both the time spent at peak fluorescence intensity 
ans the time required to return to baseline intensity levels are extended.  Finally, cells in cluster 
C exhibit an increase in fluorescence intensity, but remain at the peak intensity for the duration 
of the experiment.  We theorize that the cells in cluster A are undergoing non-apoptotic cell 
death because of the dramatic and often complete loss of fluorescence signal.  This is perhaps 
in response to the environmental stress, ionomycin exposure, or combination thereof.   Based 
upon more physiologic types of stimulation, we expect that the initial increase in fluorescence 
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induced by ionomycin to be transient in nature with intensities returning to baseline levels as in 
cluster B.  It is possible that the fall time of the fluorescent signal in cluster C is longer than the 
duration of the experiment and that intensity levels would eventually return to baseline.  While 
the exact biological mechanisms resulting in these distinct clusters of response are presently 
unknown, the ability to tease out such information within a single experiment is a major 
testament to the usefulness of this platform for the application to cellular signaling analysis.   
Cell to cell variations, even in specific subsets such as theses CD4+ T cells, can have a large 
impact upon their response to a given stimuli.  This data both illustrates the value and 
importance of single cell data in combination with bulk analysis as well as highlights the utility of 
the multi-trap nanophysiometer as it yields valuable statistical information in a minimal amount 
of time from hundreds of single cells in parallel, including their temporal activation dynamics.   
In addition to single cell analysis, another key strength of this platform is the ability to  
study cell-cell interaction as well. As shown in Figure 7D dendritic cell stimulation resulted in 
measurable pulsing of calcium transients within the T cell as the two cells interacted within the 
device.   
 
A.
B.
C.
 
Figure 20.  Clustering analysis results of calcium response from ionomysin stimulated T cells within the 
nanophysiometer. Left: Dendrogram representing the distance in N-dimensional space between green, red and blue 
type curves, where N is the number of time points. Right: Profiles of the green, red and blue subgroups top, middle and 
bottom, respectively. 
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An example of dendritic cell/ T cell interaction is shown in Figure 9. Current 
immunological methods 
for studying the 
immune synapse 
consist of large 
media:cell volume 
ratios.  One must 
simply wait for 2 cells to 
diffuse through the 
media and find each 
other in order to extract information about the interaction.  Other methods include adhering cells 
in place using antibody- or fibronectin-covered dishes.  This not only reduces time to contact for 
two cells, but also triggers internal signaling cascades caused by the antibody/fibronectin 
binding, making the interpretation of data more difficult.  The multi-trap nanophysiometer easily 
traps multiple types of cells passively, quickly, and much more predictably than current 
methods.  This ability alone has the potential for a significant impact on the approach of many 
immunological studies, since a complete immune response depends heavily on cell-cell 
interactions. 
 
Conclusions 
 The nanophysiometer is a unique and powerful microfluidic platform for the study of 
signaling dynamics in hundreds-to-thousands of single cells in parallel from very small samples. 
In this respect it is considered complimentary to flow cytometry since the dynamic responses of 
individual cells to stimuli can be recorded and used to discover phenotypic subtypes. In this 
report, we demonstrated its ability to passively trap non-adherent, primary CD4+ T cells, taken 
from samples consisting of less than 50,000 cells, and maintain them such that nearly 70% 
 
Figure 21.  Primary human dendritic cells (DCs), preactivated with LPS and SEB, 
were trapped with naïve primary human CD4+ T cells preloaded with rhod-2 
calcium indicator in the nanophysiometer.  Bright field (A) and rhod-2 
fluorescence (B) images were obtained every 30 seconds.  As shown in graph 
(C), cytosolic calcium transients were observed in T cells that were in direct 
contact with DCs, consistent with the early stages of T cell activation and the 
initiation of the immune synapse. 
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remained viable after 24 hours.  Furthermore, we successfully induced cytosolic calcium 
transients in trapped T cells using chemical, antibody, and cellular stimuli. 
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CHAPTER V 
 
 
 
REAL-TIME MONITORING OF INTERCELLULAR SIGNALING BETWEEN HUMAN 
DENDRITIC CELL AND CD4+ T CELLS USING THE MICROFLUIDIC NANOPHYSIOMETER 
 
 
 
Abstract 
 
It has long been known that stimulation of naïve T cells (TCs) by mature dendritic cells 
(DCs) occurs through both contact and non-contact-based interactions, although much attention 
is paid to the immune synapse.  However, studying the signaling events surrounding the 
immune synapse or intercellular signaling between DCs and TCs can be quite difficult using 
current cell culture methods, especially when one is interested in capturing the earliest signaling 
events.  In this report, we demonstrate a novel microfluidic platform, the nanophysiometer, 
which overcomes many limitations of current methods to allow easy, real-time data collection in 
both cell-cell interaction experiments and intercellular signaling studies in non-adherent cell 
lines.  Using the nanophysiometer in both stand-alone and daisy-chain configurations, we were 
able to observe calcium transients in TCs in response to contact as well as non-contact based 
interactions with DCs.  Further investigation into then non-contact based stimulation, we found 
that LPS matured DCs, in the absence of antigen, secrete chemical signals that cause strong 
calcium transients in naïve CD4+ TCs.  This signal was not measurable in un-concentrated cell 
culture supernatants indicating that the signaling agent is produced in small quantities, but was 
easily detected within the nanphysiometer due to its inherent low cell to media volume ratio.  
The characteristics of this signaling factor, which remains to be identified, are similar to those 
reported in the literature for DCs lipid hydrolysis products, prostaglandins, secreted exosomes, 
or prepackaged chemokine CCL19.  Future studies will focus on identifying this signaling factor 
as well as investigating other intercellular signaling events between DCs and TCs during 
immune response. 
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Introduction 
It has long been known that stimulation of naïve T cells (TCs) by mature dendritic cells 
(DCs) occurs through both contact and non-contact-based interactions, although much attention 
is paid to the immune synapse.  In the body, both DCs and TCs rely on a complex and highly 
specific array of chemokine, cytokine, and other signaling agents to navigate and home to 
lymph nodes or infection sites, as well as to differentiate into the proper functional cell 
phenotype for efficient immune response against a particular antigen[2].  However, studying the 
signaling events surrounding the immune synapse or 
intercellular signaling between DCs and TCs can be quite 
difficult using current cell culture methods, especially when one 
is interested in capturing the earliest signaling events.  In this 
report, we demonstrate a novel microfluidic platform, the 
nanophysiometer, which overcomes many limitations of current 
methods to allow easy and fast data collection on both cell-cell 
interaction experiments and intercellular signaling studies in 
non-adherent cell lines.  We have used this platform to discover 
and investigate an early intercellular signaling event occurring 
between DCs and TCs. 
A schematic of the microfluidic nanophysiometer is 
shown in Figure 1.  This platform is a self contained unit fabricated of optically transparent, bio-
inert PDMS on glass and designed to maintain non-adherent cells in a microfluidic environment 
[3].  Cells are injected into one of the inlet ports using computer-controlled micro-syringe pumps.  
As cells flow through the trap region, cells are passively trapped in one of 550 18 
µm×18µm×10µm PDMS, bucket-like structures ( see Figure 2 for close-up view of cell traps).  
Media flow rate is optimized such that cells remain in traps and receive necessary nutrients 
while minimizing shear stress and waste accumulation.  The nanophysiometer provides a 
 
 
Figure 22.  Schematic of 
microfluidic nanophysiometer. 
The device is constructed of 
PDMS and plasma-bonded to 
a glass coverslip 
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method of quickly sequestering cells into individually addressable compartments without using 
any type of adhering agents, such as cell surface antibodies, poly-l-lysine, or fibronectin, which 
can themselves induce unwanted intracellular signaling cascades.  Furthermore, only relatively 
small quantities of cells (aliquots as small as 1000 cells), media (~100s of microliters for long-
term experiments), and other reagents are required to obtain data on hundreds of single cells in 
parallel, resulting in decreased labor and material costs. 
A major strength of this platform is the ability to easily study cell-cell interaction between 
two or more cell types.  In cell culture, there normally exists a relatively large media volume:cell 
ratio, resulting in a significant time delay before any cell interaction occurs, as the cells 
passively diffuse throughout the large media volume and find partners by chance.  Two cell 
types are easily co-cultured in the nanophysiometer, however, by simply flowing both cell types 
across the trap region.  There exists almost no delay time in bringing the two cells together in 
close contact and since the traps themselves are fixed in place, it is easy to program the 
computer-controlled stage and camera system to capture images of earliest responses in cell-
cell interactions.  In addition, the low ceiling of the device (10µm) ensures that cells remain in a 
single layer within the trap region so that all physical interactions are in the optical plane of the 
microscope, another feature that is virtually uncontrollable in suspension cell culture. 
In addition to easily studying cell-cell interactions, the nanophysiometer has many 
characteristics that make it a powerful tool for analyzing non-contact-based intercellular 
signaling events.  The fact that the cell trap region of the nanophysiometer has a volume of less 
than ,20 nL. more than half of which is occupied by traps and cells, means that signaling agents 
secreted by cells are not diluted by the external media, and remain at biologically realistic 
concentrations.  This allows the observation of autocrine and paracrine signaling in real-time 
that might otherwise squelched by the preponderance of culture media.  The triangular shape of 
the cell trap region was designed such that the behaviors of cells not exposed to cell secretions 
(cells trapped in the top of the device) can be compared to those cells trapped in the back of the 
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device (which are exposed to all the secretions of cells trapped upstream).  In this paper, we 
report the observation of naïve T cell stimulation in T cells trapped downstream of mDC/TC 
pairs within a single device.  This finding led to a group of experiments investigating the early 
intercellular signals between physically separated DCs and TCs using multiple microfluidic 
devices in series.     
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Materials & Methods 
 
Experimental Setup 
All experiments were performed using an Axiovert 200 microscope (Carl Zeiss, 
Germany).  The microscope environment was modified to facilitate long-term maintenance of 
cells during experiments, as shown in Figure 2.  A plexiglass incubator enclosed the 
microscope such that the temperature was maintained at 37oC.  The nanophysiometer was 
enclosed within a modified petri dish (Fisher Scientific, Hampton NH) with holes machined in the 
bottom to allow microscope viewing, as well as slots in the top for PEEK tubing passage.  In 
addition, a port was drilled in the side of the dish to allow tubing connected to a gas supply such 
that a constant flow of 5% CO2 in 95% air was pumped into the petri dish.  To minimize 
evaporation, 3 to 4 layers of filter paper (Whatman, Florham Park NJ) saturated with dH20 were 
used to surround the device inside the petri dish.  The entire device was rigidly affixed to the 
mechanized microscope stage.  The stage, image acquisition, focus, and filter settings were 
DEVICE
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l ss
Inlet
Ports
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Figure 23.  Schematic illustrating the standard experimental setup. 
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controlled using Metamorph software (Molecular Devices, Downington PA).  Syringe pump flow 
rates were also ,controlled utilizing custom software developed by VIIBRE researchers.  Images 
were obtained with the electrically cooled CoolSNAP HQ CCD camera (Photometrics, Tucson 
AZ).  
 
Cell Culture 
Primary human CD4+ T cells and dendritic cells (derived from human monocytes) were 
generously provided by the lab of Derya Unutmaz (New York University School of Medicine, 
New York, NY) following isolation and purification from human blood donors [1].  Primary CD4+ 
T cells were thawed  from liquid nitrogen aliquots (5*105 cells/vial) 24 hours prior to use and 
cultured using sterile technique in RPMI 1640 (ATCC, Manassas VA) supplemented with 10% 
FBS (ATCC, Manassas VA) and 10µg/ml Ciprofloxacin (Mediatech, Herndon VA).  Dendritic 
cells were derived by incubating primary human CD14+ monocytes with 20 ng/ml IL-4 and 
100ng/ml GM-CSF for 4-6 days [4].  Mature dendritic cells were generated following 24-hour 
incubation with 10 ng/ml LPS [4].  All cells were incubated in a sterile environment maintained at 
37oC, complete with 5% CO2 and 95% humidity. 
 
Microfluidic Cell Loading 
Cell loading followed methods developed by our lab and described in greater detail in 
previous publication [5].  Cells were centrifuged to a pellet at 5000 rpm for 1 minute in 1.5 ml 
eppendorf tubes (Fisher Scientific, Hampton NH) which were then mounted on a glass slide for 
viewing the pellet with the microscope.  Once the pellet was located using the microscope, 50 
µm I.D. PEEK tubing (Upchurch, Oak Harbor WA), connected to 50 µl gas-tight syringe 
mounted on a computer controlled syringe pump (Harvard Apparatus, Holliston MA), was 
guided to the cell pellet.  Cells were then aspirated directly into the PEEK tubing using the 
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syringe pump set to reverse at a flow-rate of 0.5 
µl/min.  The tubing was then inserted to a loading 
channel of a device pre-cleared with sterile media.  
This cell loading procedure required approximately 
10 minutes and is illustrated in Figure 3. Once all 
inputs were connected to the device, the pump 
controlling the cell channel was set to a forward flow 
rate of 100 nl/min for passive loading of cells into the 
traps as they traverse the device.  Unless otherwise noted, the media used to perfuse the 
device and the cells contained within consisted of RPMI 1640 supplemented with 10% FBS and 
10µg/ml ciprofloxacin. 
 
Cytosolic Calcium Assay 
Release of intracellular calcium stores and subsequent calcium flux, an early signaling 
event in T cell activation, was induced chemically, with antibody-coated beads, or by co-
incubation with antigen-presenting cells.  In all cases, naïve primary CD4+ T cells were first 
loaded with rhod-2 calcium indicator by incubation in a 5µM solution for 30 minutes at 37oC.  
Cells were then loaded into the nanophysiometer (pre-cleared with media to remove air 
bubbles) and perfused with normal culture media supplemented with CaCl2 to a final 
concentration of 1.8 mM[6].  Using Metamorph software, the microsope was programmed to 
obtain baseline bright field (DIC or phase-contrast) and TRITC (rhod-2 fluorescence) images for 
4 to 5 FOVs spanning the entire cell trap region of the microfluidic device every 30 seconds. 
The images were numbered sequentially and saved automatically to disk. 
Figure 24  Macro cell culture to micro cell culture 
in microfluidic devices. Use of ultra small bore 
tubing to aspirate controllable volumes of high 
cell-density and seed into device. 
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APC Stimulation. LPS stimulated, primary human dendritic cells (DCs) were obtained 
from the Unutmaz lab on the day of experiment.  Prior to loading, the DCs were incubated with 
20 ng/ml of SEB for thirty minutes at 37oC [4].  DCs were 
then rinsed with fresh media to remove all unbound SEB.  
The resuspended cells were then centrifuged to a pellet for 
cell loading as described above.  TCs were trapped first, 
and then DCs introduced to the devices.  Image acquisition 
began upon introduction of DCs. 
Daisy-chain Configuration.  Two separate devices 
were prepared just as described above, except that 
instead of inserting the devices into a specially cut petri 
dish, the polystyrene chambers from a single chambered 
converglass (Nunc, Fisher Scientifc, Hampton, NH) was 
detached from its original coverslip and adhered to the 
glass coverslip bonded to the microfluidic device, in order 
to create a small area to control CO2 and humidity levels. Both devices were secured to a 
custom machined stage insert that is capable of accommodating and imaging up to six devices 
in the same experiment. Filter paper saturated with water and CO2 were added as before.  One 
device was loaded with naïve CD4+ T cells only.  The other device was loaded with the TC 
stimulus of interest (e.g., mature dendritic cells).  Background data was collected every 30 
seconds on both devices running on completely separate pump systems.  To connect the two 
devices, one of the inlets on the TC device pushing plain media was cut and the cut end 
inserted into the exit port of the other device, such that the downstream TCs were exposed to 
the effluent of the cells in the first device. Figure 4 illustrates the daisy-chain setup for studying 
intercellular signaling. Image acquisition was restarted immediately following reconnection and 
continued for at least one hour. 
 
Figure 25.  Schematic of daisy-chain 
device conformation.   Prior to daisy-
chain connection, the PEEK tubing 
connecting the two devices is initially 
connected to a syringe pump pushing 
plain media through the second 
(downstream) device.  During 
connection, this line is cut and the cut 
end is inserted into the exit port of the 
first device. 
  82 
 
Figure 26.  Calcium transient observed in a naïve CD4+ T cell stimulated by 
interaction with a mature DC.  T cells were incubated with 5 µM rhod-2 AM 
ester prior to experiment[1].  Bright field snapshots of the cells are shown in 
(A) and the corresponding fluorescence images are shown in (B).  Graph (C) 
shows the fluctuation in fluorescence over time, indicating a clear cytosolic 
calcium increase in the TC following contact with the DC. 
 
Results 
 As shown in Figure 5, naïve T cells elicit cytosolic calcium burst when in direct contact 
with a mature dendritic cell 
while trapped within the 
microfluidic nanophysiometer.  
This is a well-known signaling 
cascade initiated by the 
interaction between the MHC 
(in this case, aided by the 
super-antigen, SEB) and the T 
cell receptor which results in calcium release from the sarcoplasmic reticulum.  The calcium 
responses derived from these contact-based interactions are consistent with the literature and 
were entirely expected.  Interestingly, however, during the course of experiments it was noted 
that some CD4+ T cells that were in no detectable physical contact with dendritic cells also 
elicited a calcium response.  This observation led to a series of experiments investigating the 
nature of intercellular signaling occurring between dendritic cells and T cells. 
 In order to ensure that what triggered a calcium transient in the naïve CD4+ cells was 
indeed a factor present in the perifusate, rather  than being the result of long, barely visible 
extensions of the dendritic cells, a new setup was devised to physically separate the two cell 
populations.  Two identical microfluidic devices were utilized to house one cell population each, 
in a configuration shown in Figure 4.  After collecting baseline data, the two devices were 
connected in a daisy-chain fashion, such that the exit port of the first device (containing the 
stimulus, i.e., dendritic cells) was connected to an inlet port of the second device (containing 
naïve CD4+ T cells).  This arrangement results in the cells in the second device being exposed 
  83 
to the all the signaling factors secreted into the perifusate by the cells trapped in the upstream 
device. 
 The first experiment utilizing the daisy-chain device configuration involved mature 
dendritic cells and naïve T cells trapped together in the first (upstream) device.  The second 
device contained only naïve T cells.  Just as observed in the single trap experiment, calcium 
transients were observed in both the T cells in contact with the dendritic cells (upstream device) 
as well as those in the T cells 
trapped in the downstream device.  
Figure 6 illustrates the non-contact-
dependent calcium transients 
induced in the T cells trapped in the 
second device.  Interestingly, the 
calcium transients were induced 
very quickly – within minutes of 
connecting the daisy-chain.   
 Once it was verified that 
there was indeed a stimulatory factor transmitted in a non-contact-dependent manner, we 
sought to identify its source.  This involved evaluating both different upstream cellular 
populations as well as chemicals such as SEB and LPS that were undoubtedly being 
transferred in the media.  A comparison of control to experimental data is shown in Figure 7. 
Graphs A – C clearly demonstrate that calcium transients are not induced from plain media, 
SEB, or LPS.  The stimulatory signal is cell-based.  In addition, note that a sharp jump in rhod-2 
fluorescence is observed in the naïve T-cell population in the downstream device and occurs 
within seconds to minutes of the daisy-chain being connected. The stimulus in this case was 
mature dendritic cells pre-pulsed with SEB.  The ensuing stimulation of calcium release in the 
downstream cell revealed that the DCs were in fact the source of the stimulating factor.  
 
Figure 27. Non-contact based stimulation of cytosolic calcium flux in naïve 
CD4+ TCs trapped in nanophysiometer daisy-chained downstream of a 
device containing mature DCs and TC together.  Image acquisition began 
upon daisy-chain connection.  Bright field images of the cells are shown in 
(A) with the corresponding fluorescence images shown in (B).  TCs were 
incubated with 5 µM rhod-2 prior to experiment.  Graph (C) indicates the 
fluctuation in fluorescence intensities of the cells.  Each line represents a 
single cell.  Cytosolic calcium transients are clearly seen in TC within 
minutes of daisy-chain connection. 
  84 
 Table 1 summarizes the experiments conducted to further characterize the source of the 
stimulatory factor.  We evaluated the stimulation ability of mature DCs pulsed with SEB and 
paired with naïve T cells, mature DCs pulsed with SEB, mature DCs (no SEB), naïve DCs, 
naïve TCs, SEB alone, LPS alone, and finally, the supernatant taken from mature DCs (no SEB) 
incubated in a cell culture dish for 24 hours at a concentration of 5∗105 and 5∗106 DCs per 
milliter of media (LPS concentration held constant).  The analysis revealed that mature DCs 
secrete the stimulating factor and that neither pulsing with SEB nor incubation with naïve T cells 
was necessary for production.  In addition, the fact that the supernatant from cultured mature 
DCs was unable to elicit a calcium response suggests that the stimulatory factor exists in very 
small concentrations.  This hypothesis was supported by the fact that concentrating DCs tenfold 
 
Figure 28.  Monitoring cytosolic calcium levels in  naïve T cells exposed to (A) plain media (RPMI 1640+ 10% 
FBS+10 µg/ml Cipro+20 ng/ml IL2), (B) plain media supplemented with 5 µg/ml LPS, (C) plain media supplemented 
with 5 nM SEB, and (D) Daisy-chained to a device upstream which contained mature DCs only.  Each line 
represents a single cell analyzed over the entirety of the experiment.  T cells were incubated with 5 µM rhod-2 AM-
ester prior to the experiments. No calcium activity is observed in response to plain media or LPS.  Some calcium 
activity is observed with the addition of SEB, as expected, but the relative intensity of this response is quite small 
compared to that shown in graph D.  Within seconds to minutes, T cells respond with distinct cytosolic calcium 
transient to the effluent from mature DCs.  It is clear that the DCs are secreting a signaling factor that stimulates this 
calcium release in T cells. 
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Table 1.  The left column describes the agent 
used to stimulate naïve CD4+ TCs within the 
nanophysiometer.  The right hand column 
indicates whether or not a measurable 
cytosolic calcium transient was observed in 
the TCs  Each stimulus was exposed to the 
TCs for at least an hour.  Cell-based stimuli 
were daisy-chained upstream to the naïve TCs 
while fluid based stimuli (LPS, SEB, cell 
culture supernatants) were simply introduced 
in an alternate port of the device containing 
the TCs.. 
(essentially reducing the media volume:cell ratio) 
resulted in supernatant that did induce calcium transient 
in naïve T cells. 
 While the factor secreted by mature DCs 
stimulated calcium transients in the naïve T cells, we 
wanted to determine if it was truly a pro-stimulatory 
factor, or one that perhaps might have an overall 
inhibitory effect towards complete T cell activation.  To 
examine this question, mature DCs were daisy-chained 
upstream of naïve TCs as in previous experiments.  After 
allowing the TCs in the second device to be exposed to 
the effluent from the first device containing DC, the 
daisy-chain was disconnected and a bolus of mature, 
SEB pulsed DCs were injected into the second device.  We then compared the calcium 
response of cells exposed to the secreted factor followed by direct DC contact to those 
stimulated by DC contact alone.  The results 
are shown in Figure 8.  We found that cells 
initially exposed to the stimulatory factor 
(“factor x” in the graph) were subsequently 
able to be stimulated by DC contact.  This 
suggests that the factor secreted by DCs 
does not have an inhibitory effect on TC 
activation, at least in terms of initiating 
calcium release from intracellular stores.  
Whether or not this signaling molecule functions to enhance TC activation, however, still 
remains to be determined. 
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Figure 29.  Comparison of rhod-2 signal strength in naïve 
CD4+TCs exposed to DC contact only, “factor x” only and 
“factor x” followed by DC contact.  While neither “factor x” nor 
“factor x + DC contact” resulted in the same magnitude of 
response seen in cells only exposed to DCs, the overall 
calcium signal did increase once the cell exposed to “factor x” 
were in contact with DCs.  This suggests that “factor x” is at 
least not inhibitory to TC activation, and is likely a pro-
stimulatory agent. 
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Discussion 
In this report we have demonstrated a novel microfluidic platform for studying both cell-
cell interactions and intercellular signaling events of non-adherent cells.  The nanophysiometer 
employs hydrodynamic forces to passively trap and retain suspension cells in static, individually 
addressable, PDMS buckets, thereby bypassing the need for specialized cell isolation or 
adherence techniques.  Previous studies characterizing cell viability within the microfluidic 
nanophysiometer revealed that the primary TCs remained both viable and active for 24 hours 
[3].  Results of our cell-cell interaction experiments involving mDCs and naïve TCs revealed 
cytosolic calcium transients in TCs with clear oscillations, a characteristic calcium burst pattern 
first reported by Donnadieu et al. [7].  This lends support to our assertion that trapped cells are 
at least as functional as those utilized in standard cell culture experiments.  Compared to 
standard cell culture techniques, the nanohpysiometer facilitiates the capture of hundreds of 
these DC-TC interactions in a single experiment, rather than a few chance encounters.  
Furthermore, the physical interaction between TCs and DCs within the nanophysiometer is quite 
similar to that observed in vivo [8], with rings of nTCs circling individual mDCs (data not shown).   
Utilizing the nanophyisiometer in a daisy-chain configuration allowed us to confirm that in 
the absence of antigen, mDCs release soluble signaling agent(s) that induce cytosolic calcium 
transient in naïve CD4+ TCs.  For the ease of communication, we have termed the TC stimulus 
“factor x,” with the knowledge that the mDCs may be releasing more than one signaling factor 
that causes the subsequent calcium release.  While the existence of intercellular signaling 
between DCs and TCs is anything but new, these results lend further support to the utility of 
applying the nanophysiometer to immunological study, especially when analyzing cellular 
products that may occur in small quantities.  Furthermore, these results raise interesting 
questions into the nature of these early, pre-synaptic communications between DCs and TCs.  
One could clearly envision “factor x” having chemotactic properties, as mDCs ready for antigen 
presentation would like to traffic and/or stimulate TCs trafficking to lymph nodes.  Increased TC 
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motility and sampling of nearby mDCs would also be desirable in the early stages of immune 
response.  The concentration of “factor x” is relatively small, suggesting that either it is meant to 
act locally, as in supporting synapse formation, or the signal is generated in sufficient 
concentrations in vivo to propagate the signal.  Another possibility is that mDCs continually 
produce small amounts of “factor x,” thereby causing an accumulation of the signaling agent 
over time.   
Due to the rapid transmission of the stimulatory signal from DCs to TCs upon daisy-
chain connection, it is possible that rather than a chemokine/cytokines signal, “factor x” could be 
a signaling molecule, such as a lipid hydrolysis product[9;10] or prostaglandin, which does not 
require de novo synthesis, and all of which are known to induce calcium transients in TCs.  It is 
clear that if “factor x” is a cytokine/chemokine, it is one whose production is stimulated by 
maturation of the DC in the presence of LPS and prepackaged for release.  This raises the 
questions of whether maturation by other agents might effect the expression of “factor x” and at 
what point during maturation its secretion begins, two areas currently under investigation in our 
lab.  
Because the experiments presented here stop short of identifying “factor x,” we can only 
speculate on its identity and function.  However, several reports in the literature provide a few 
potential candidates.  Segura et al. report that both immature and mature DCs secret exosomes 
that are capable of interacting with nTCs and inducing calcium release [11].  In the absence of 
antigen, DCs matured using LPS were found to produce exosomes with increased levels of 
DC86, ICAM-1, and MHC ΙΙ compared to exosomes produced by immature DCs, all of which 
can induce calcium transients in naïve CD4+ TCs.  Exosomes have even been shown to 
transfer MHC peptide complexes to nTCs [12].  Furthermore, they found a very similar activation 
trend, as shown in Figure 8.  Exosomes secreted by mDCs induced calcium transients in TCs 
that were weaker than when TCs were stimulated by mDCs (still in the absence of antigen).  
When stimulated by mDCs following exposure to exosomes, the intensity of the calcium signal 
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rose, but not to the level of mDC alone[11].  In terms of the identity of “factor x,” secreted 
exosomes are quite feasible given the timescale in which the signal is observed and the similar 
pattern of calcium transients observed. 
Another interesting report by Kaiser et al. asserts that even in the absence of antigen, 
mDCs secrete chemokine CCL19, which stimulates nTCs via the cell surface receptor, CCR7, 
resulting in cytosolic calcium transients [13].  Similar to our findings, supernatant taken from 
LPS matured DCs failed to result in nTC stimulation, although the authors note that presence of 
supernatant enhanced calcium response in TCs interacting with mDCs.  Since CCL19 is not an 
adhesion protein, it is hypothesized that mDCs release the chemokine to act locally on nearby 
TCs to enhance synapse formation.  Others report that CCL19 is secreted by mDCs in vivo as a 
potent attractor of nTCs [14].   
Current experiments in our lab focus on identifying “factor x,” including investigating the 
possibilities of exosomes or CCL19 being the culprit, as well as proteomic analysis of mDC 
supernatant to yield other possible signaling molecules.  In addition, we plan to utilize the 
nanophysiometer to study in greater depth the events leading up to and surrounding the 
initiation of secretion of stimulatory signals from DCs, as well as their long-term effects on TC 
activation.  It will be of great interest to learn if these pre-synaptic signals can influence Th1/Th2 
orientation since DC chemokine and cytokine secretions are known to have a great impact on 
this transition [15-19].  As mentioned earlier, we are interested in looking into differences in 
maturation agents upon the release of chemical signals by mDCs.  Because the 
nanophysiometer allows data collection on hundreds of cells in parallel in any given experiment, 
we can begin to run statistical analysis on the calcium response patterns, and perhaps even 
determine whether different DC maturation agents result in characteristic calcium response 
patterns[2;15-17;20-27]. 
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Conclusions 
 In this report we demonstrate a unique and powerful microfluidic platform for studying 
both cell-cell interaction and intercellular signaling events in non-adherent immune cells.  The 
novelty of this platform lies in the ability to passively trap and maintain hundreds of non-
adherent cells in parallel, easily and quickly dictate the physical location of cells, obtain temporal 
data on any given cells, function in low cell:volume environment such that cellular secretions are 
not diluted and effects are monitored in real-time, and, because of the small dimension, require 
very few cells and reagents to obtain large amounts of data.  We have successfully utilized this 
platform to show that DCs matured with LPS, but in the absence of antigen, release low 
concentrations of a chemical signal that stimulates cytosolic calcium release in nTCs.  Future 
experiments will continue to investigate both intercellular and intracellular signaling events 
surrounding the immune synapse. 
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CHAPTER VI 
 
 
A REPORT OF DYE TRANSFER BETWEEN DENDRITIC CELLS AND CD4+ T CELLS 
DURING SYNAPSE FORMATION 
 
 
 
Abstract 
A concert of intricate exchanges between immune cells lies at the core of adaptive 
immune response, whereby critical antigenic information is communicated and the general 
environmental survey performed by antigen presenting cells is transformed into a highly specific 
cell-mediated attack against the infecting agent. While it is clear that some information is passed 
by way of cell surface ligand/receptor binding events during the immunological synapse 
between dendritic cells and T cells, there are also paracrine intercellular signaling events that 
impact the development of immune response.  Understanding how immune cells communicate 
with one another is key to fully deciphering the signals leading to immune response, tolerance, 
and anergy.  We have developed a microfluidic platform, termed the nanophysiometer, to study 
non-adherent immune cell interactions and signaling pathways.  Utilizing the nanophysiometer 
to investigate calcium signaling in T cells during the immunological synapse, dye transfer 
between T cells and dendritic cells was observed.  Further analysis revealed that bi-directional 
dye transfer occurs during the immunological synapse.  This suggests that the communication 
between T cells and dendritic cells during the immune synapse involves cytosolic transfer. 
 
Introduction 
A concert of intricate exchanges between immune cells lies at the core of adaptive 
immune response, whereby critical antigenic information is communicated and the general 
environmental survey performed by antigen presenting cells is transformed into a highly specific 
cell-mediated attack against the infecting agent [1].  The immunological synapse, perhaps the 
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most well known of these intercellular exchanges, is widely accepted as the physical medium by 
which dendritic cells (DCs) transmit antigen information to naïve T cells (TCs), resulting in TC 
activation [2-4].  While it is clear that some information is passed 
by way of cell surface ligand/receptor binding events which trigger 
intracellular signaling cascades, a complete understanding of what 
information and the method by which it is translated remains 
under investigation [5-9].  Understanding how immune cells 
communicate with one another is key to fully deciphering the 
signals leading to immune response, tolerance, and anergy. 
We have developed a microfluidic platform, termed the 
nanophysiometer, to study non-adherent immune cell interactions 
and signaling pathways.  A schematic of the microfluidic 
nanophysiometer is shown in Figure 1.  This platform is a self-
contained unit fabricated of optically transparent, bio-inert PDMS 
on glass and designed to maintain non-adherent cells in a microfluidic environment [10].  Cells 
are injected into one of the inlet ports using computer-controlled micro-syringe pumps.  As cells 
flow through the trap region, they are passively trapped in one of 550 18 µm×18µm×10µm 
PDMS, bucket-like structures.  Media flow rate is optimized such that cells remain in traps and 
receive necessary nutrients while minimizing shear stress and waste accumulation.  The 
nanophysiometer provides a method of quickly sequestering cells into individually addressable 
compartments without using any adhering agents, such as cell surface antibodies, poly-l-lysine, 
or fibronectin, which can themselves induce unwanted intracellular signaling cascades.  
Furthermore, only relatively small quantities of cells (aliquots as small as 1000 cells), media 
(less than 1 ml is required for long-term experiments), and other reagents are required to obtain 
data on hundreds of single cells in parallel, resulting in decreased labor and material costs 
compared with bulk cell culture techniques. 
Figure 30. Schematic of 
microfluidic nanophysiometer. 
The device is constructed of 
PDMS and plasma-bonded to 
a glass coverslip. 
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We utilized the nanophysiometer to investigate interactions between mDCs and TCs.  In 
this paper, we report the observation of bi-directional dye transfer between DCs and TCs at 
various stages of immune synapse formation.  We hypothesize that this reveals a very important 
communication method employed by both cell types during the development of effective 
immune response. 
 
Materials & Methods 
A description of the experimental setup, nanophysiometer preparation, and cell loading 
can be found in [11].  Primary human CD4+ T cells and dendritic cells (derived from human 
monocytes) were generously provided by the lab of Derya Unutmaz (New York University 
School of Medicine, New York, NY) following isolation and purification from human blood donors 
[12].  Primary CD4+ T cells were thawed from liquid nitrogen aliquots (5*105 cells/vial) 24 hours 
prior to use and cultured using sterile technique in RPMI 1640 (ATCC, Manassas VA) 
supplemented with 10% FBS (ATCC, Manassas VA) and 10µg/ml Ciprofloxacin (Mediatech, 
Herndon VA).  Dendritic cells were derived by incubating primary human CD14+ monocytes 
with 20 ng/ml IL-4 and 100ng/ml GM-CSF for 4-6 days [13].  Mature dendritic cells were 
generated following 24-hour incubation with 10 ng/ml LPS [13].  All cells were incubated in a 
sterile environment maintained at 37oC, complete with 5% CO2 and 95% humidity. 
Naïve primary CD4+ T cells were first loaded with rhod-2 calcium indicator by incubation 
in a 5µM solution for 30 minutes at 37oC.  The same protocol was utilized to load mDCs with 
CellTracker Green (Molecular Probes), except the media contained a 1mM concentration of the 
dye.  Cells were then loaded into the nanophysiometer (pre-cleared with media to remove air 
bubbles) and perfused with normal culture media supplemented with CaCl2 to a final 
concentration of 1.8 mM [14].  Using Metamorph software, the microscope was programmed to 
obtain baseline bright field (DIC or phase-contrast) and TRITC (rhod-2 fluorescence) images for 
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4 to 5 FOVs spanning the entire cell trap region of the microfluidic device at precise time 
intervals.  
 
Results 
The first observation of dye transfer occurred during an experiment investigating long-
term calcium signaling in primary, naïve CD4+ TCs during immune synapse interaction with 
mature, SEB pulsed DCs.  Only the TCs were loaded with rhod-2 calcium indicator dye prior to 
the experiment.  Unexpectedly, we found that roughly 10% of the DCs interacting with TCs 
exhibited a measurable fluorescent signal for short periods of time.  An example is shown in 
Figure 2.  Because the only known source of rhod-2 calcium dye was that free in the cytosol of 
the TCs, it is hypothesized that 
the fluorescent signal seen in 
the DCs is a result of cytosolic 
transfer from the TC to the DC 
during their interactions.  To 
test if the observed transfer 
was due to the dye associating 
with the TC membrane, the 
experiment was repeated 
using CellTracker Green with 
the same results (data not shown). 
Following the observation of the TC to DC dye transfer, we asked whether such a 
transfer could occur in the opposite direction, from DCs to TCs.  For this experiment, only the 
DCs were loaded with CellTracker Green prior to the experiment.  Although the DC to TC dye 
transfer was a rarer occurrence, we were able to capture several events, one of which is shown 
in Figure 3.  In this series of images, a DC uses its cellular extensions to capture a TC as it 
 
Figure 31.  Dye transfer from rhod-2 loaded, naïve primary CD4+ TC 
trapped alongside a mature, SEB pulse DC.  Bright field images are 
shown in (A) and the corresponding fluorescence images in (B).  A 
graphical representation of the fluorescence intensity of the two cells 
over time is shown in (C). 
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passes.  One striking difference observed 
in the DC to TC dye transfer events is the 
time scale on which it occurs.  The DC to 
TC transfers occur very quickly after 
physical contact, while TC to DC transfer 
occurs only after the two cells have 
maintained physical contact for an 
extended periods of time. 
 
Discussion 
 In this brief report we present evidence for a new type of interaction occurring between 
mDCs and TCs during the immune synapse which includes the exchange of cytosolic material, 
as shown through dye transfer observations.  It is our hypothesis that the immunological 
synapse , in addition to facilitating the interaction of cell surface proteins for the exchange of 
information, may also include a conduit for the direct exchange of mass.  What molecular  
species may be transferred this way remains to be identified.  There are reports of cell 
membrane proteins, such as MHC II, being transferred from DCs to TCs[15;16].  If these 
proteins are transferred in patches of cell membrane in a process known as trogocytosis that 
occurs in DCs and TCs [17-19], it is feasible to think that perhaps bits of cytosol are transferred 
as well.   
Another possibility is that there are channels or junctions formed during the 
immunological synapse.  Gap junctions have been demonstrated as a method of peptide 
transfer between two cells [20] and have selective permeabilities [21].  There are reports of DCs 
forming gap junctions with neighboring DCs as well as other cell types, such as B cells and 
other endothelial cells [22-24].  In fact, it is thought that intercellular communication between 
DCs in the lymph nodes is essential to effective DC maturation [22].  Gap junctions are formed 
 
Figure 32.  Dye transfer from a mature, SEB pulsed 
DC loaded with CellTracker Green to a naïve CD4+ 
T cell.  The bright field images are shown in (A) and 
the corresponding fluorescence images in (B). 
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by organization of connexin proteins within the cell membrane.  DCs are known to express 
connexin 40 and 43 [25;26].  While direct evidence of gap junction formation during the immune 
synapse has yet to be proven, it is known that TCs also express connexin 43 and thus have the 
potential to form gap junctions with other cells [27]. 
Another interesting observation in these dye transfer experiments is the time scale on 
which the transfer took place.  It appears as though DC to TC dye transfer occurs very quickly 
following physical contact of the two cells while TC to DC transfer takes place several hours into 
their interaction.  Currently this is simply an observation, as not enough events have been 
documented to yield statistical significance in any case.  We can speculate, however, that it is 
not improbable for DCs to be eager to quickly transmit antigenic information to nTCs when 
seeking to stimulate an immune response.  It is important for DCs to find a TC that responds to 
the captured antigen as quickly as possible, often briefly interacting with hundreds to thousands 
of TCs in the process.  The TC to DC transfer may only occur after the immunological synapse 
is fully organized.  In any case, this presents a very interesting area for further investigation into 
the interaction between DCs and TCs.  Perhaps it can yield greater insight into the methods 
utilized by these cells to decide between immune response or suppression. 
 
Conclusions 
 Because immune cells are non-adherent, traditional cell culture methods are ill-equipped 
to study cell-cell interactions and must utilize additional adhesion methods to secure cells to a 
known physical place.  These adhesion techniques often obscure normal cell morphology and 
induce intracellular signaling pathways that may interfere with data analysis.  Using a novel 
microfluidic platform, we examined the interactions between mDCs and naïve CD4+ TCs during 
the immunological synapse.  We observed bi-directional dye transfer between mDCs and TCs 
that suggest cytosolic exhange occurs during their interactions.  The direction of dye transfer 
was dependent upon the duration of interaction with DC to TC transfer very quickly following 
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physical contact, while TC to DC transfer occurred several hours into synapse formation.  This 
may hold many clues as to how and when information is communicated between DCs and TCs 
during the immunological synapse.   
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CHAPTER VII 
 
CONCLUSIONS & FUTURE DIRECTIONS 
 
This body of work describes the major accomplishments attained towards the 
development, validation, and application of a novel microfluidic platform designed to study T cell 
signaling.  Platform compatible, antibody-conjugated QDs were shown to be accurate indicators 
of IL2Rα cell surface expression in T cells during activation.  These will be useful for future long-
term activation studies within the nanophysiometer as IL2Rα expression peaks 24 hours 
following T cell activation.  In terms of the platform itself, the results presented here validate the 
nanophysiometer as a powerful, cell-based instrument to study multiple single cells in parallel.  
Not only was it demonstrated that primary T cells can be passively contained within the cell trap 
region using only hydrodynamic forces, but also that cells can be maintained under continuous 
flow conditions for 24 hours with viability approaching 70%.  Furthermore, we successfully 
activated T cells within the nanophysiometer using chemical, antibody, and cellular based 
stimulation methods.   
Following this validation, we then employed the nanophysiometer to study signaling 
events associated with the early stages of T cell activation.  By utilizing the nanophysiometer in 
a daisy-chain configuration, we were able to confirm that DCs matured with LPS, but in the 
absence of antigen, release small quantities of a chemical signal that induces cytosolic calcium 
transients in naïve T cells without any physical interaction.  This intercellular signaling 
phenomenon was not apparent in a standard cell culture environment due to the large volume of 
media diluting the signal, highlighting another attribute of the nanophysiometer as the 20 
nanoliter volume of the cell trap region greatly decreases the cell to media volume ratio and 
allows the effects of low concentration chemical signals to be observed.  Because autocrine and 
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paracrine signaling is highly influential during immunological synapse formation and the 
progression of immune response, the nanophysiometer has the potential to have a significant 
impact upon immunological research as there exist very few tools to study large quantities of 
individual suspension cells over time while maintaining a low cell to media volume ratio.  
Furthermore, the ability to either study cell-cell interaction or to physically separate the cells 
offers a useful flexibility to the platform for modeling various biologically relevant situations, such 
as the signaling events between DCs and TCs during the immunological synapse compared to 
DC cells in the lymph node with TCs in the periphery.   
Finally, we report evidence of dye transfer between mature DCs and naïve TC during 
early interactions leading to the immunological synapse.  The relative number of cell pairs that 
showed signs of dye transfer was only 10%, but observation was made possible by monitoring 
hundreds of cell-cell interactions over time within the nanophysiometer.  Dye transfer was 
observed from TCs to DCs and vice versa, although on different time scales suggesting some 
specificity in information communicated between the cells.  DC to TC dye transfer occurred very 
quickly after making superficial contact while TC to DC transfers occurred following hours of 
interaction.  These results suggest that communication between DCs and TCs during the 
immunological synapse is not limited to cell surface ligand-receptor pairs initiating intracellular 
signaling cascades.  Understanding the biology behind the observed dye transfer events will 
undoubtedly reveal important information concerning the role of the immunological synapse in 
effective immune response. 
Future directions for the further development of the nanophysiometer include modeling 
the fluid dynamics as well as incorporating additional technologies to probe cellular signaling 
states.  Currently, sensors to monitor cellular metabolism as well as technology to detect cellular 
secretions, such as cytokines or chemokines, are under development and planned to be 
incorporated into the nanophysiometer platform, thus expanding our detection capabilities.  The 
applications of the nanophysiometer to study immune biology are practically endless.  We plan 
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to continue studying the interactions between DCs and TCs during the immunological synapse 
in the immediate future.  Experiments include narrowing down the possible identity of “factor x” 
from the list of potential culprits. It will also be interesting to examine whether various maturing 
agents affect the chemical signals secreted by DCs.  Furthermore, to study how the chemical 
signals impact T cell activities in the presence or absence of DC contact.  Of course, the dye 
transfer experiments are still in the very early phases and warrant further investigation into the 
nature of the channel/junction that facilitates cytosolic exchange.   
A secondary impetus for this work is derived from dire need for reliable chemical and 
biological warfare (CBW) detection system.  Recent world events have resulted in heightened 
concern over the threat of chemical & biological warfare (CBW) agents and renewed interest in 
elucidating mechanisms of detection, prevention, treatment, and containment of large scale 
disease epidemics.  While detection systems and treatment protocols against naturally 
occurring diseases such as small pox and anthrax are already being implemented, these efforts 
do not address the more concerning issue of maliciously engineered biological agents.  This 
yields the question: how do you construct a detection system with the ability to sense novel 
pathogens with completely unknown pathogenesis?  We believe that the adaptive immune 
response is an ideal model for such a system as this is exactly what the immune system is 
designed to accomplish within the body.  Since T cells are posses’ inherent discriminatory ability 
along with responsive intracellular signaling pathways, we believe that they are excellent 
candidates for utilization as biosensors.  The same microfluidic platform designed to study the 
signaling pathways of T cells has the potential to be a useful tool in the field or field laboratory 
due to is small size, ease and low cost of production, as well as the ability to be integrated with 
multiple detection modalities.  Thus, the development of this microfluidic platform can not only 
impact the necessary basic biological research of T cell signaling pathways during the course of 
an immune response, but may also potentially be utilized  as a tool for detecting unknown CBW 
toxins in the field.    
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 There is much more detail to the activation of T cells than is discussed within this 
dissertation, much if which is still under investigation.  The choice between T cell activation 
versus anergy is a function of TCR affinity for MHC + pathogenic peptide [1] , presence of co-
factors and adhesion proteins[2;3], cytoskeletal rearrangements [4], inflammatory cytokines[5], 
the activation of any cytosolic inhibitory proteins [6], as well as signals yet to be identified.  
Furthermore, activated CD4+ cell then differentiate into either TH1 or TH2 effector cells 
depending upon the interactions occurring during the immune synapse which determined 
whether there will be a humoral or cell based T cell response[7].  There are situations such as 
pregnancy and tumorigenesis that, according to the traditional model of adaptive immune 
response, should lead to acute inflammatory reaction and rejection, but, for reasons not entirely 
clear, result in immune tolerance.  Conversely, a completely MHC matched donated organ 
 
Figure 3.  Schematic illustrating the use of T cells as biosensors.  We begin with two identical T cells, one of 
which is exposed to an unknown toxin.  The two cells are then exposed to activating factors which may 
consist of antigen presenting cells (APCs), artificial antigen presenting cells (aAPCs), chemicals such as 
PMA and ionomycin, or antibodies.  The normal T cell will go on to upregulate IL2R and IL2, as well as other 
known processes associated with T cell activation.  The cell exposed to toxin, however, will have an altered 
activation process.  This may take the form of anergy, or upregulation of atypical proteins for activation.  In 
the end, the normal cell that is completely activated will begin to divide whereas the toxin exposed cell might 
die or become anergic.  We plan to go back and determine what signaling pathways the toxin effects within 
the T cell.  By doing so, we hypothesize that the manner in which the toxin effects the cell can be used to 
discriminate between toxins.  In addition, because we are dealing with cells of the immune system, 
understanding what pathways have been disturbed will aid in understanding a toxin’s method of 
pathogenesis and provide valuable insights into treatment. 
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suffers from acute and chronic immune rejection despite the use of immune suppressive 
medications.  Matzinger proposed the concept that T cells are capable of not just discriminating 
between self and non-self, but actually goes a step further and differentiates between 
dangerous versus non-dangerous signals[8;9]. Clearly, there exists a high level of complexity 
and discriminatory ability within the signaling pathways of T cells.  These characteristics not only 
allow these cells to be highly effective for mediating immune response against novel pathogens, 
but also to be utilized as biosensors to gain insight into methods of detection, prevention, and 
treatment for biological warfare agents (see Figure .  The premise being that T cells exposed 
directly (not via APCs) to a particular toxin will subsequently yield unique signatures in the form 
of promotion or inhibition of particular signaling events or molecules.  After toxin exposure, T 
cells that are subsequently activated using chemicals or artificial APCs will exhibit changes in 
the known signaling cascades that can be identified and used for identification and 
discrimination against other potential CBW agents.  Studies concerning anthrax toxin conducted 
by Paccani et al support the feasibility of this premise as they have shown both the lethal factor 
(LF) and edema factor (EF) of anthrax toxin suppress T cell activation by inhibiting the MAPK 
dependant NFAT and AP-1 signaling pathways [10].   This work illustrates an additional benefit 
of using T cells as biosensors in that the information collected is not only useful for identifying 
pathogens, but also provides details concerning its impact upon the adaptive immune response.  
This is highly relevant is developing preventative and therapeutic treatments. 
Ultimately, however, the nanophysiometer is intended to be a tool to be utilized to gather 
important information regarding T cell signaling states.  Significant progress towards this goal 
had been made by validating the nanophysiometer as a platform capable of sustaining primary 
T cells and demonstrating that valuable information can be extracted.  In order to continue to 
progress it is necessary to develop and incorporate optical probes to study the intracellular 
signaling pathways as well as the additional detection technologies for monitoring cellular 
metabolism and secretions.  In addition, it is necessary to also works towards identifying the 
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pathways of importance beyond those already known during T cell activation.  The results 
presented here prove that the current capabilities of this platform are quite powerful and that it 
should be continued to be developed as both a tool for CBW detection as well as a technology 
to investigate cellular signaling activities in general. 
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